Known interventions
Find interventions linked to a surface target in the campaign’s clinical-trial and ligand records. Open a record to inspect the reported target and source.
How interventions connect to targets
Recorded interventions
| Intervention | Target(s) | Action | Format | Status |
|---|---|---|---|---|
212Pb-DOTAM-GRPR1Source studies (1)Record ID: I-CTG-212pb-dotam-grpr1-28e4663353 | gastrin-releasing peptide receptor | antagonist; radionuclide-delivery | radioligand-therapy | RECRUITING |
[111In]-FPI-1967Source studies (1)Record ID: I-CTG-111in-fpi-1967-89b7f5ed6d | fibroblast growth factor receptor 3 | Not recorded | molecular-imaging-agent | TERMINATED |
[111In]-FPI-2107Source studies (1)Record ID: I-CTG-111in-fpi-2107-37ea0ec994 | epidermal growth factor receptor, hepatocyte growth factor receptor | Not recorded | molecular-imaging-agent | ACTIVE_NOT_RECRUITING |
[111In]In-DOTA-ANTI-CEA antibody injectionSource studies (1)Record ID: I-CTG-111in-in-dota-anti-cea-antibody-injection-db4657027f | carcinoembryonic antigen-related cell adhesion molecule 5 | Not recorded | molecular-imaging-agent | UNKNOWN |
[18F]F-RESCA-G5Source studies (1)Record ID: I-CTG-18f-f-resca-g5-733d72e44e | glypican-3 | molecular-imaging | molecular-imaging-agent | RECRUITING |
[18F]F-RESCA-RB14Source studies (1)Record ID: I-CTG-18f-f-resca-rb14-b3e631ee50 | receptor tyrosine-protein kinase erbB-2 | molecular-imaging | molecular-imaging-agent | RECRUITING |
[18F]F-RESCA-RND20Source studies (1)Record ID: I-CTG-18f-f-resca-rnd20-5136376ed7 | nectin cell adhesion molecule 4 | molecular-imaging | molecular-imaging-agent | RECRUITING |
[18F]F-RESCA-T4Source studies (2)Record ID: I-CTG-18f-f-resca-t4-35b147630c | tumor-associated calcium signal transducer 2 | molecular-imaging | molecular-imaging-agent | RECRUITING |
[18F]F-RESCA-WWH347Source studies (1)Record ID: I-CTG-18f-f-resca-wwh347-2c82aa5ec4 | cell surface A33 antigen | molecular-imaging | molecular-imaging-agent | RECRUITING |
[225Ac]-FPI-1966Source studies (1)Record ID: I-CTG-225ac-fpi-1966-e299fbd736 | fibroblast growth factor receptor 3 | Not recorded | radioligand-therapy | TERMINATED |
[225Ac]-FPI-2068Source studies (1)Record ID: I-CTG-225ac-fpi-2068-86d75ffcc8 | epidermal growth factor receptor, hepatocyte growth factor receptor | Not recorded | radioligand-therapy | ACTIVE_NOT_RECRUITING |
[68Ga]-NeoBOMB1Source studies (1)Record ID: I-CTG-68ga-neobomb1-9353e21018 | gastrin-releasing peptide receptor | Not recorded | molecular-imaging-agent | TERMINATED |
[68Ga]Ga-DOTA-H2D3Source studies (1)Record ID: I-CTG-68ga-ga-dota-h2d3-c90970f5a7 | receptor tyrosine-protein kinase erbB-2 | molecular-imaging | molecular-imaging-agent | RECRUITING |
[68Ga]Ga-FL-261 PET Imaging / [111In]In-FL-261 SPECT ImagingSource studies (1)Record ID: I-CTG-68ga-ga-fl-261-pet-imaging-111in-in-fl-261-1cd979f4ad | hepatocyte growth factor receptor | Not recorded | molecular-imaging-agent | RECRUITING |
[68Ga]Ga-NOTA-G5Source studies (1)Record ID: I-CTG-68ga-ga-nota-g5-6d44b3e9a5 | glypican-3 | molecular-imaging | molecular-imaging-agent | RECRUITING |
[68Ga]Ga-NOTA-RND20Source studies (1)Record ID: I-CTG-68ga-ga-nota-rnd20-882a3bd082 | nectin cell adhesion molecule 4 | molecular-imaging | molecular-imaging-agent | RECRUITING |
[68Ga]Ga-NOTA-T4Source studies (2)Record ID: I-CTG-68ga-ga-nota-t4-9e339e2328 | tumor-associated calcium signal transducer 2 | molecular-imaging | molecular-imaging-agent | RECRUITING |
[68Ga]Ga-NOTA-WWH347Source studies (1)Record ID: I-CTG-68ga-ga-nota-wwh347-6c428e5c54 | cell surface A33 antigen | molecular-imaging | molecular-imaging-agent | RECRUITING |
A166Source studies (1)Record ID: I-CTG-a166-64561330f1 | receptor tyrosine-protein kinase erbB-2 | cytotoxic-payload-delivery | antibody-drug-conjugate | COMPLETED |
AB680Source studies (1)Record ID: I-CTG-ab680-d446c5ca53 | ecto-5-prime-nucleotidase | inhibitor | small-molecule | COMPLETED |
AMG 479Source studies (2)Record ID: I-CTG-amg-479-f079f70775 | insulin-like growth factor 1 receptor | binder | antibody | COMPLETED / TERMINATED |
anti-CD133-CAR vector-transduced T cellsSource studies (1)Record ID: I-CTG-anti-cd133-car-vector-transduced-t-cells-71f6e37e6a | prominin-1 | Not recorded | car-t-cell-therapy | COMPLETED |
anti-CEA CAR-T cellsSource studies (4)Record ID: I-CTG-anti-cea-car-t-cells-a8afa7bb5a | carcinoembryonic antigen-related cell adhesion molecule 5 | Not recorded | car-t-cell-therapy | COMPLETED / RECRUITING / WITHDRAWN |
Anti-CEA-CAR TSource studies (2)Record ID: I-CTG-anti-cea-car-t-7a15bcb339 | carcinoembryonic antigen-related cell adhesion molecule 5 | Not recorded | car-t-cell-therapy | UNKNOWN |
anti-EGFR monoclonal antibodySource studies (1)Record ID: I-CTG-anti-egfr-monoclonal-antibody-11294839cd | epidermal growth factor receptor | Not recorded | antibody | COMPLETED |
Anti-EGFR-Containing RegimenSource studies (1)Record ID: I-CTG-anti-egfr-containing-regimen-079e0c7097 | epidermal growth factor receptor | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Anti-HER2 CAR-TSource studies (1)Record ID: I-CTG-anti-her2-car-t-c75d83eaec | receptor tyrosine-protein kinase erbB-2 | Not recorded | car-t-cell-therapy | WITHDRAWN |
anti-MUC1 CAR-pNK cellsSource studies (1)Record ID: I-CTG-anti-muc1-car-pnk-cells-ec10721779 | mucin-1 | Not recorded | car-nk-cell-therapy | UNKNOWN |
anti-MUC1 CAR-T cellsSource studies (1)Record ID: I-CTG-anti-muc1-car-t-cells-7dae37eda8 | mucin-1 | Not recorded | car-t-cell-therapy | UNKNOWN |
anti-PD-1 antibodySource studies (1)Record ID: I-CTG-anti-pd-1-antibody-0f75f0b392 | programmed cell death protein 1 | Not recorded | antibody | COMPLETED |
Anti-PD-1 monoclonal antibodySource studies (1)Record ID: I-CTG-anti-pd-1-monoclonal-antibody-83ef48eab2 | programmed cell death protein 1 | Not recorded | antibody | UNKNOWN |
Anti-PD-L1 Monoclonal AntibodySource studies (1)Record ID: I-CTG-anti-pd-l1-monoclonal-antibody-b15c504477 | programmed death-ligand 1 | Not recorded | antibody | RECRUITING |
AtezolizumabSource studies (8)Record ID: I-CTG-atezolizumab-5dd1e8658b | programmed death-ligand 1 | binder; blocker; inhibitor | antibody | ACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED |
avelumabSource studies (5)Record ID: I-CTG-avelumab-b59aea15d3 | programmed death-ligand 1 | binder; blocker | antibody | COMPLETED / TERMINATED / WITHDRAWN |
BalstilimabSource studies (3)Record ID: I-CTG-balstilimab-5a47b9bd23 | programmed cell death protein 1 | Not recorded | antibody | ACTIVE_NOT_RECRUITING |
CAR T cellsSource studies (1)Record ID: I-CTG-car-t-cells-c5bd1845e7 | mesothelin | Not recorded | car-t-cell-therapy | UNKNOWN |
CAR-T cell immunotherapySource studies (2)Record ID: I-CTG-car-t-cell-immunotherapy-1ef738f219 | epithelial cell adhesion molecule | Not recorded | car-t-cell-therapy | UNKNOWN |
CAR-T cells targeting EpCAMSource studies (1)Record ID: I-CTG-car-t-cells-targeting-epcam-552a0c6e28 | epithelial cell adhesion molecule | Not recorded | car-t-cell-therapy | UNKNOWN |
CDH17 CAR-TSource studies (1)Record ID: I-CTG-cdh17-car-t-5fafb7c24d | cadherin-17 | Not recorded | car-t-cell-therapy | RECRUITING |
CEA-targeted CAR-T cellsSource studies (5)Record ID: I-CTG-cea-targeted-car-t-cells-716275dc4a | carcinoembryonic antigen-related cell adhesion molecule 5 | Not recorded | car-t-cell-therapy | COMPLETED / RECRUITING / UNKNOWN |
Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)]Source studies (1)Record ID: I-CTG-cemiplimab-fianlimab-fixed-dose-combinatio-2883943204 | cytotoxic T-lymphocyte protein 4, programmed cell death protein 1 | Not recorded | other-or-unclear | NOT_YET_RECRUITING |
CetuximabSource studies (58)NCT00005076 NCT00020917 NCT00020930 NCT00061815 NCT00063141 NCT00079066 NCT00083720 NCT00125034 NCT00154102 NCT00226941 NCT00326495 NCT00397384 NCT00436072 NCT00444678 NCT00503685 NCT00719199 NCT00784667 NCT00803647 NCT00845039 NCT00925015 NCT01074333 NCT01152437 NCT01167725 NCT01198535 NCT01225744 NCT01254617 NCT01292356 NCT01442935 NCT01450319 NCT01522612 NCT01719380 NCT01925274 NCT02164916 NCT02291289 NCT02563002 NCT02671435 NCT02713373 NCT02994888 NCT03169777 NCT03186326 NCT03319459 NCT03356158 NCT04464967 NCT04485013 NCT04515394 NCT04587128 NCT04800822 NCT04853043 NCT04929223 NCT05395052 NCT05694936 NCT05720559 NCT05774964 NCT06118047 NCT06440902 NCT07020221 NCT07318805 NCT07411599 Record ID: I-CTG-cetuximab-22d728a3c3 | epidermal growth factor receptor | antagonist; binder; inhibitor | antibody | ACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED / UNKNOWN / WITHDRAWN |
Chimeric antigen receptor T cell preparation targeting GCCSource studies (1)Record ID: I-CTG-chimeric-antigen-receptor-t-cell-preparati-2461b7b2f2 | guanylate cyclase 2C | Not recorded | car-t-cell-therapy | UNKNOWN |
CHM-2101 CAR-T cellsSource studies (1)Record ID: I-CTG-chm-2101-car-t-cells-1f528dedbe | cadherin-17 | Not recorded | car-t-cell-therapy | RECRUITING |
Copper Cu 64 Anti-CEA Monoclonal Antibody M5ASource studies (1)Record ID: I-CTG-copper-cu-64-anti-cea-monoclonal-antibody--1c38eaff9c | carcinoembryonic antigen-related cell adhesion molecule 5 | Not recorded | antibody | ACTIVE_NOT_RECRUITING |
CP-751, 871Source studies (1)Record ID: I-CTG-cp-751-871-7112346d32 | insulin-like growth factor 1 receptor | Not recorded | antibody | COMPLETED |
CPI-006Source studies (1)Record ID: I-CTG-cpi-006-7295548d5e | ecto-5-prime-nucleotidase | Not recorded | antibody | COMPLETED |
CT-0508Source studies (1)Record ID: I-CTG-ct-0508-e0402d4074 | receptor tyrosine-protein kinase erbB-2 | Not recorded | other-or-unclear | UNKNOWN |
Cu 64 anti-CEA monoclonal antibody M5A IVSource studies (1)Record ID: I-CTG-cu-64-anti-cea-monoclonal-antibody-m5a-iv-ffd848d4d4 | carcinoembryonic antigen-related cell adhesion molecule 5 | Not recorded | antibody | ACTIVE_NOT_RECRUITING |
Datopotamab deruxtecan (Dato-DXd)Source studies (1)Record ID: I-CTG-datopotamab-deruxtecan-dato-dxd-90cdcc43e0 | tumor-associated calcium signal transducer 2 | Not recorded | antibody-drug-conjugate | RECRUITING |
DurvalumabSource studies (5)Record ID: I-CTG-durvalumab-a8c0108ba9 | programmed death-ligand 1 | binder; blocker | antibody | ACTIVE_NOT_RECRUITING / COMPLETED |
EB-DUO-CAR-NK-CEA/GCCSource studies (1)Record ID: I-CTG-eb-duo-car-nk-cea-gcc-9ddb5588c2 | carcinoembryonic antigen-related cell adhesion molecule 5, guanylate cyclase 2C | Not recorded | car-nk-cell-therapy | RECRUITING |
EB-DUO-CAR-NK-CEA/GCC (IV)Source studies (1)Record ID: I-CTG-eb-duo-car-nk-cea-gcc-iv-ea153d70da | carcinoembryonic antigen-related cell adhesion molecule 5, guanylate cyclase 2C | Not recorded | car-nk-cell-therapy | RECRUITING |
EPCAM CAR-TSource studies (1)Record ID: I-CTG-epcam-car-t-6e829ef49b | epithelial cell adhesion molecule | Not recorded | car-t-cell-therapy | UNKNOWN |
FAST LACO-Stim CDH17 CAR-TSource studies (1)Record ID: I-CTG-fast-laco-stim-cdh17-car-t-41ef783a2e | cadherin-17 | Not recorded | car-t-cell-therapy | RECRUITING |
favezelimab/pembrolizumabSource studies (2)Record ID: I-CTG-favezelimab-pembrolizumab-4da1038787 | lymphocyte activation gene 3 protein, programmed cell death protein 1 | Not recorded | bispecific-antibody | COMPLETED |
Fruquintinib combined with anti-PD-1 antibodiesSource studies (1)Record ID: I-CTG-fruquintinib-combined-with-anti-pd-1-antib-d7689fe1ff | programmed cell death protein 1 | Not recorded | antibody | COMPLETED |
GanitumabSource studies (2)Record ID: I-CTG-ganitumab-5365bed8a8 | insulin-like growth factor 1 receptor | Not recorded | antibody | COMPLETED |
IBI3028Source studies (1)Record ID: I-CTG-ibi3028-ff981e0ea3 | epidermal growth factor receptor, hepatocyte growth factor receptor | cytotoxic-payload-delivery | antibody-drug-conjugate | RECRUITING |
IM96 CAR-T cellsSource studies (1)Record ID: I-CTG-im96-car-t-cells-111524d9e1 | guanylate cyclase 2C | Not recorded | car-t-cell-therapy | UNKNOWN |
Intraperitoneal infusion of FAST CEA-targeted CAR-TSource studies (1)Record ID: I-CTG-intraperitoneal-infusion-of-fast-cea-targe-5d1a5c7453 | carcinoembryonic antigen-related cell adhesion molecule 5 | Not recorded | car-t-cell-therapy | RECRUITING |
investigator choice re-challenge with anti EGFR RxSource studies (1)Record ID: I-CTG-investigator-choice-re-challenge-with-anti-9694a696df | epidermal growth factor receptor | Not recorded | antibody | UNKNOWN |
iodine I 123 anti-CEA recombinant diabody T84.66Source studies (1)Record ID: I-CTG-iodine-i-123-anti-cea-recombinant-diabody--bd95c1eb88 | carcinoembryonic antigen-related cell adhesion molecule 5 | Not recorded | molecular-imaging-agent | COMPLETED |
Iodine-124 labeled humanized A33 (antibody)Source studies (1)Record ID: I-CTG-iodine-124-labeled-humanized-a33-antibody-e8caa6e23e | cell surface A33 antigen | Not recorded | molecular-imaging-agent | COMPLETED |
JS207Source studies (1)Record ID: I-CTG-js207-13bb7c5a22 | programmed cell death protein 1 | Not recorded | bispecific-antibody | RECRUITING |
JS212Source studies (1)Record ID: I-CTG-js212-0f8ea7a70b | epidermal growth factor receptor, receptor tyrosine-protein kinase erbB-3 | cytotoxic-payload-delivery | bispecific-antibody-drug-conjugate | RECRUITING |
KeytrudaSource studies (1)Record ID: I-CTG-keytruda-8266394dac | programmed cell death protein 1 | binder; blocker | antibody | NOT_YET_RECRUITING |
KT032(anti-MSLN chimeric antigen receptor autologous T cell injection)Source studies (1)Record ID: I-CTG-kt032-anti-msln-chimeric-antigen-receptor--6cffa98224 | mesothelin | Not recorded | car-t-cell-therapy | NOT_YET_RECRUITING |
long course radiotherapy + capecitabine + PD-1 monoclonal antibody treatment combinationsSource studies (1)Record ID: I-CTG-long-course-radiotherapy-capecitabine-pd-1-717aefe155 | programmed cell death protein 1 | Not recorded | antibody | UNKNOWN |
NimotuzumabSource studies (1)Record ID: I-CTG-nimotuzumab-9d33f20df6 | epidermal growth factor receptor | Not recorded | antibody | COMPLETED |
nivolumabSource studies (22)Record ID: I-CTG-nivolumab-af64a27aa2 | programmed cell death protein 1 | binder; blocker; inhibitor | antibody | ACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / SUSPENDED / TERMINATED / WITHDRAWN |
OleclumabSource studies (2)Record ID: I-CTG-oleclumab-ad0acf4f20 | ecto-5-prime-nucleotidase | Not recorded | antibody | COMPLETED |
panitumumabSource studies (14)Record ID: I-CTG-panitumumab-b41fb4011c | epidermal growth factor receptor | antagonist; inhibitor | antibody | ACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED / UNKNOWN |
pembrolizumabSource studies (23)Record ID: I-CTG-pembrolizumab-d8acadde7d | programmed cell death protein 1 | binder; inhibitor | antibody | ACTIVE_NOT_RECRUITING / COMPLETED / ENROLLING_BY_INVITATION / NOT_YET_RECRUITING / RECRUITING / TERMINATED / UNKNOWN |
PertuzumabSource studies (4)Record ID: I-CTG-pertuzumab-fc1d976b9c | receptor tyrosine-protein kinase erbB-2 | Not recorded | antibody | ACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING |
radionuclide imagingSource studies (1)Record ID: I-CTG-radionuclide-imaging-4ddc489e17 | carcinoembryonic antigen-related cell adhesion molecule 5 | Not recorded | molecular-imaging-agent | ACTIVE_NOT_RECRUITING |
RamucirumabSource studies (2)Record ID: I-CTG-ramucirumab-3e3bf3aa35 | vascular endothelial growth factor receptor 2 | Not recorded | antibody | RECRUITING |
Ramucirumab Injection [Cyramza]Source studies (1)Record ID: I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c | vascular endothelial growth factor receptor 2 | antagonist; binder; blocker; inhibitor | antibody | COMPLETED |
Recombinant Anti-EGFr AntibodySource studies (1)Record ID: I-CTG-recombinant-anti-egfr-antibody-95e6a19c1f | epidermal growth factor receptor | Not recorded | antibody | COMPLETED |
Recombinant full human Anti-EGFR Monoclonal AntibodySource studies (1)Record ID: I-CTG-recombinant-full-human-anti-egfr-monoclona-465bb5f843 | epidermal growth factor receptor | Not recorded | antibody | UNKNOWN |
RegorafenibSource studies (6)Record ID: I-CTG-regorafenib-9aec6927fe | vascular endothelial growth factor receptor 2 | inhibitor | small-molecule | ACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING |
regorafenib plus anti-PD-1 antibodiesSource studies (1)Record ID: I-CTG-regorafenib-plus-anti-pd-1-antibodies-89d65224dd | programmed cell death protein 1 | Not recorded | antibody | COMPLETED |
sasanlimabSource studies (2)Record ID: I-CTG-sasanlimab-dd86800660 | programmed cell death protein 1 | Not recorded | antibody | TERMINATED |
SGM-101Source studies (5)Record ID: I-CTG-sgm-101-3d31779152 | carcinoembryonic antigen-related cell adhesion molecule 5 | molecular-imaging | molecular-imaging-agent | COMPLETED / RECRUITING / UNKNOWN |
sintilimabSource studies (2)Record ID: I-CTG-sintilimab-77dca9d617 | programmed cell death protein 1 | Not recorded | antibody | NOT_YET_RECRUITING / RECRUITING |
Sintilimab (IBI308)+bevacizumab+oxaliplatin+capecitabineSource studies (1)Record ID: I-CTG-sintilimab-ibi308-bevacizumab-oxaliplatin--9f8d711e91 | programmed cell death protein 1 | Not recorded | conventional-cytotoxic-regimen | UNKNOWN |
Sintilimab+mFOLFOX6 or FOLFIRI+bevacizumab or cetuximabSource studies (1)Record ID: I-CTG-sintilimab-mfolfox6-or-folfiri-bevacizumab-6e665e903a | programmed cell death protein 1 | inhibitor | conventional-cytotoxic-regimen | RECRUITING |
SOC (anti-PD-1 + platinum -based chemo)Source studies (1)Record ID: I-CTG-soc-anti-pd-1-platinum-based-chemo-fa3d4d0cf3 | programmed cell death protein 1 | Not recorded | other-or-unclear | TERMINATED |
Standard-of-care treatment with panitumumabSource studies (1)Record ID: I-CTG-standard-of-care-treatment-with-panitumuma-dd47c9ecad | epidermal growth factor receptor | Not recorded | antibody | COMPLETED |
TislelizumabSource studies (3)Record ID: I-CTG-tislelizumab-45f8cec74e | programmed cell death protein 1 | inhibitor | antibody | ACTIVE_NOT_RECRUITING / RECRUITING / TERMINATED |
TQB2102 InjectionSource studies (1)Record ID: I-CTG-tqb2102-injection-fe523b8bde | receptor tyrosine-protein kinase erbB-2 | cytotoxic-payload-delivery | antibody-drug-conjugate | NOT_YET_RECRUITING |
TQB2618 injectionSource studies (1)Record ID: I-CTG-tqb2618-injection-1e9a8d0d95 | T-cell immunoglobulin and mucin-domain containing-3 | Not recorded | antibody | UNKNOWN |
TQB2922 injection ± TAS-102 tabletsSource studies (1)Record ID: I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f | epidermal growth factor receptor, hepatocyte growth factor receptor | binder; blocker | bispecific-antibody | RECRUITING |
TQB2922 injection+TAS-102 tablets ± BevacizumabSource studies (1)Record ID: I-CTG-tqb2922-injection-tas-102-tablets-bevacizu-862724615d | epidermal growth factor receptor, hepatocyte growth factor receptor | binder; blocker | bispecific-antibody | RECRUITING |
TQB2930 injection + Oxaliplatin injection + Capecitabine tabletsSource studies (1)Record ID: I-CTG-tqb2930-injection-oxaliplatin-injection-ca-64a50abf1a | receptor tyrosine-protein kinase erbB-2 | binder | conventional-cytotoxic-regimen | NOT_YET_RECRUITING |
TQB2930 injection + Oxaliplatin injection + Capecitabine tablets + Bevacizumab injectionSource studies (1)Record ID: I-CTG-tqb2930-injection-oxaliplatin-injection-ca-f14a3dfa1c | receptor tyrosine-protein kinase erbB-2 | binder | conventional-cytotoxic-regimen | NOT_YET_RECRUITING |
trastuzumabSource studies (9)Record ID: I-CTG-trastuzumab-672bb991dc | receptor tyrosine-protein kinase erbB-2 | inhibitor | antibody | ACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED / WITHDRAWN |
tucatinibSource studies (3)Record ID: I-CTG-tucatinib-096d38d2ad | receptor tyrosine-protein kinase erbB-2 | Not recorded | small-molecule | ACTIVE_NOT_RECRUITING / RECRUITING / WITHDRAWN |
vobramitamab duocarmazineSource studies (1)Record ID: I-CTG-vobramitamab-duocarmazine-50a4e37d35 | CD276 antigen | Not recorded | antibody-drug-conjugate | TERMINATED |
vobramitamab duocarmazine 2.0 mg (Arm A)Source studies (1)Record ID: I-CTG-vobramitamab-duocarmazine-2-0-mg-arm-a-070889dad2 | CD276 antigen | Not recorded | antibody-drug-conjugate | TERMINATED |
vobramitamab duocarmazine 2.7 mg (Arm B)Source studies (1)Record ID: I-CTG-vobramitamab-duocarmazine-2-7-mg-arm-b-61467fa51b | CD276 antigen | Not recorded | antibody-drug-conjugate | TERMINATED |
vofatamabSource studies (1)Record ID: I-CTG-vofatamab-eb0c930491 | fibroblast growth factor receptor 3 | Not recorded | antibody | TERMINATED |
yttrium Y 90 DOTA anti-CEA monoclonal antibody M5ASource studies (1)Record ID: I-CTG-yttrium-y-90-dota-anti-cea-monoclonal-anti-961f658b9c | carcinoembryonic antigen-related cell adhesion molecule 5 | Not recorded | radioligand-therapy | COMPLETED |
ZanidatamabSource studies (3)Record ID: I-CTG-zanidatamab-ab22a9e067 | receptor tyrosine-protein kinase erbB-2 | Not recorded | bispecific-antibody | RECRUITING |
ZimberelimabSource studies (1)Record ID: I-CTG-zimberelimab-7422e0c132 | programmed cell death protein 1 | Not recorded | antibody | COMPLETED |
αPD1-MSLN-CAR T cellsSource studies (1)Record ID: I-CTG-pd1-msln-car-t-cells-2d2d907322 | mesothelin | Not recorded | car-t-cell-therapy | UNKNOWN |
[111In]-FPI-2058Source studies (1)Record ID: I-CTG-111in-fpi-2058-acfaea1b28 | neurotensin receptor 1 | molecular-imaging | molecular-imaging-agent | TERMINATED |
[225]-FPI-2059Source studies (1)Record ID: I-CTG-225-fpi-2059-cbaa866dc3 | neurotensin receptor 1 | radionuclide-delivery | radioligand-therapy | TERMINATED |
AMG 655Source studies (2)Record ID: I-CTG-amg-655-488f67c71e | tumor necrosis factor receptor superfamily member 10B | binder | antibody | COMPLETED / TERMINATED |
anti-CTLA-4 antibodySource studies (1)Record ID: I-CTG-anti-ctla-4-antibody-d6dc4b60f3 | cytotoxic T-lymphocyte protein 4 | Not recorded | antibody | COMPLETED |
Anti-SEMA4D Monoclonal Antibody VX15/2503Source studies (1)Record ID: I-CTG-anti-sema4d-monoclonal-antibody-vx15-2503-7692562550 | semaphorin-4D | Not recorded | antibody | COMPLETED |
AvastinSource studies (1)Record ID: I-CTG-avastin-f9a8fcc9c3 | vascular endothelial growth factor A | Not recorded | antibody | TERMINATED |
BevacizumabSource studies (42)NCT00636610 NCT00819780 NCT01167725 NCT01205022 NCT01327612 NCT01442935 NCT01588990 NCT01775644 NCT02291289 NCT02563002 NCT02671435 NCT02835833 NCT02848443 NCT03082209 NCT03169777 NCT03186326 NCT03250832 NCT03380689 NCT03607643 NCT03715933 NCT04262687 NCT04527068 NCT04587128 NCT04660812 NCT04929223 NCT04999761 NCT05007132 NCT05482516 NCT05489211 NCT05719558 NCT06003998 NCT06047379 NCT06400472 NCT06448364 NCT06696768 NCT06784947 NCT06856837 NCT06887218 NCT07277270 NCT07318805 NCT07407465 NCT07503756 Record ID: I-CTG-bevacizumab-8446a83051 | vascular endothelial growth factor A | blocker; inhibitor | antibody | ACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED / UNKNOWN / WITHDRAWN |
Bevacizumab BiosimilarSource studies (1)Record ID: I-CTG-bevacizumab-biosimilar-a36da74e4d | vascular endothelial growth factor A | Not recorded | antibody | NOT_YET_RECRUITING |
Bevacizumab InjectionSource studies (3)Record ID: I-CTG-bevacizumab-injection-b001eba9fa | vascular endothelial growth factor A | Not recorded | antibody | COMPLETED / SUSPENDED / UNKNOWN |
BotensilimabSource studies (3)Record ID: I-CTG-botensilimab-fc49d21f07 | cytotoxic T-lymphocyte protein 4 | Not recorded | antibody | ACTIVE_NOT_RECRUITING |
CAR-T infusionSource studies (1)Record ID: I-CTG-car-t-infusion-933023072e | NKG2-D type II integral membrane protein | Not recorded | car-nk-cell-therapy | UNKNOWN |
Claudin18.2-targeted CAR-DCsSource studies (1)Record ID: I-CTG-claudin18-2-targeted-car-dcs-af64bdaa0d | claudin-18 isoform 2 | Not recorded | cellular-therapy | RECRUITING |
Claudin18.2-targeted CAR-T CellsSource studies (1)Record ID: I-CTG-claudin18-2-targeted-car-t-cells-84d6f72ad0 | claudin-18 isoform 2 | Not recorded | car-t-cell-therapy | RECRUITING |
CNTO 328; Anti-interleukin-6 monoclonal antibodySource studies (1)Record ID: I-CTG-cnto-328-anti-interleukin-6-monoclonal-ant-18a7114fa4 | interleukin-6 | Not recorded | antibody | COMPLETED |
EtrumadenantSource studies (1)Record ID: I-CTG-etrumadenant-9cc45271d9 | adenosine A2A receptor, adenosine A2B receptor | antagonist | small-molecule | COMPLETED |
FruquintinibSource studies (3)Record ID: I-CTG-fruquintinib-990786ee64 | vascular endothelial growth factor receptor family | inhibitor | small-molecule | ACTIVE_NOT_RECRUITING / NOT_YET_RECRUITING / RECRUITING |
INBRX-109Source studies (1)Record ID: I-CTG-inbrx-109-fb6bab3c3e | tumor necrosis factor receptor superfamily member 10B | agonist | other-or-unclear | RECRUITING |
IpilimumabSource studies (15)Record ID: I-CTG-ipilimumab-b766c43ce0 | cytotoxic T-lymphocyte protein 4 | binder; blocker | antibody | ACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED / WITHDRAWN |
NKG2D CAR-NKSource studies (1)Record ID: I-CTG-nkg2d-car-nk-f396e4aac1 | NKG2-D type II integral membrane protein | Not recorded | car-nk-cell-therapy | UNKNOWN |
TiragolumabSource studies (2)Record ID: I-CTG-tiragolumab-dd38477944 | T-cell immunoreceptor with Ig and ITIM domains | inhibitor | antibody | ACTIVE_NOT_RECRUITING / RECRUITING |
TocilizumabSource studies (2)Record ID: I-CTG-tocilizumab-85bf04378e | interleukin-6 receptor subunit alpha | Not recorded | antibody | TERMINATED |
Trifluridine /Tipiracil (TAS-102) tablets / Fruquintinib / Regorafenib tabletsSource studies (1)Record ID: I-CTG-trifluridine-tipiracil-tas-102-tablets-fru-6a185e2f56 | vascular endothelial growth factor receptor family | blocker; inhibitor | small-molecule | NOT_YET_RECRUITING |
TTX-080Source studies (1)Record ID: I-CTG-ttx-080-be60161d02 | HLA class I histocompatibility antigen, alpha chain G | Not recorded | antibody | RECRUITING |
(Early) Imaging of response with [18F-]-FDG PET-CT and kinase activity profilesSource studies (1)Record ID: I-CTG-early-imaging-of-response-with-18f-fdg-pet-4fdfa2a180 | Not recorded | Not recorded | molecular-imaging-agent | COMPLETED |
1 mg 89Zr-DFO-NimotuzumabSource studies (1)Record ID: I-CTG-1-mg-89zr-dfo-nimotuzumab-ad74941ac3 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
111Indium CHX-ASource studies (1)Record ID: I-CTG-111indium-chx-a-65ae89ac97 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
120mg Regorafenib at week2Source studies (1)Record ID: I-CTG-120mg-regorafenib-at-week2-4113c8b27c | Not recorded | Not recorded | small-molecule | WITHDRAWN |
160 mg Regorafenib at week 3Source studies (1)Record ID: I-CTG-160-mg-regorafenib-at-week-3-cd13ed6b64 | Not recorded | Not recorded | small-molecule | WITHDRAWN |
177Lu-BetaBartSource studies (1)Record ID: I-CTG-177lu-betabart-fb338b61db | Not recorded | Not recorded | radioligand-therapy | RECRUITING |
18F-FDGSource studies (1)Record ID: I-CTG-18f-fdg-8a2b994805 | Not recorded | Not recorded | molecular-imaging-agent | ACTIVE_NOT_RECRUITING |
18F-αvβ6-BPSource studies (1)Record ID: I-CTG-18f-v-6-bp-08e45d3cef | Not recorded | Not recorded | molecular-imaging-agent | ACTIVE_NOT_RECRUITING |
1H Spectroscopy at 1.5T and 3TSource studies (1)Record ID: I-CTG-1h-spectroscopy-at-1-5t-and-3t-d2b75d3f74 | Not recorded | Not recorded | procedure-or-device | COMPLETED |
203Pb-DOTAMSource studies (1)Record ID: I-CTG-203pb-dotam-965dd78c82 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
212Pb-DOTAMSource studies (1)Record ID: I-CTG-212pb-dotam-a9d2afc7be | Not recorded | Not recorded | radioligand-therapy | RECRUITING |
350 mg leronlimabSource studies (1)Record ID: I-CTG-350-mg-leronlimab-788ba15886 | Not recorded | Not recorded | antibody | ACTIVE_NOT_RECRUITING |
5-FluorouracilSource studies (5)Record ID: I-CTG-5-fluorouracil-54c81ae48b | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED / RECRUITING / TERMINATED |
5-Fluorouracil (5-FU)Source studies (1)Record ID: I-CTG-5-fluorouracil-5-fu-70024f00b0 | Not recorded | Not recorded | conventional-cytotoxic-regimen | WITHDRAWN |
5-FluouracilSource studies (1)Record ID: I-CTG-5-fluouracil-02062800ef | Not recorded | Not recorded | other-or-unclear | COMPLETED |
5-FUSource studies (5)Record ID: I-CTG-5-fu-e38b30c404 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED / UNKNOWN |
5-FU/LVSource studies (1)Record ID: I-CTG-5-fu-lv-7780ef39f8 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
5-HT3 antagonistSource studies (1)Record ID: I-CTG-5-ht3-antagonist-70ee71046f | Not recorded | antagonist | other-or-unclear | COMPLETED |
50 mg 89Zr-DFO-NimotuzumabSource studies (1)Record ID: I-CTG-50-mg-89zr-dfo-nimotuzumab-97671e4dcf | Not recorded | Not recorded | other-or-unclear | RECRUITING |
5FU/LVSource studies (1)Record ID: I-CTG-5fu-lv-6f078c1a90 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
6-month adjuvant chemotherapy with 5-FU monotherapySource studies (1)Record ID: I-CTG-6-month-adjuvant-chemotherapy-with-5-fu-mo-10b1416de5 | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING |
700 mg leronlimabSource studies (1)Record ID: I-CTG-700-mg-leronlimab-38a4c1ed26 | Not recorded | Not recorded | antibody | ACTIVE_NOT_RECRUITING |
700mg leronlimab weekly doseSource studies (1)Record ID: I-CTG-700mg-leronlimab-weekly-dose-cda1c365e6 | Not recorded | Not recorded | antibody | WITHDRAWN |
80mg Regorafenib at week 1Source studies (1)Record ID: I-CTG-80mg-regorafenib-at-week-1-ad37cdaf9e | Not recorded | Not recorded | small-molecule | WITHDRAWN |
9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine (Hansenula Polymorpha)Source studies (1)Record ID: I-CTG-9-valent-human-papillomavirus-types-6-11-1-25b4049687 | Not recorded | Not recorded | vaccine | ACTIVE_NOT_RECRUITING |
[177Lu]Lu-A9-0631Source studies (1)Record ID: I-CTG-177lu-lu-a9-0631-66f6221fe7 | Not recorded | Not recorded | radioligand-therapy | RECRUITING |
[18F]F-RESCA-EPCD6Source studies (1)Record ID: I-CTG-18f-f-resca-epcd6-8dea9211d8 | Not recorded | Not recorded | molecular-imaging-agent | RECRUITING |
[18F]F-RESCA-RT4Source studies (1)Record ID: I-CTG-18f-f-resca-rt4-052aca8d82 | Not recorded | Not recorded | molecular-imaging-agent | RECRUITING |
[225Ac]Ac-A9-0642Source studies (1)Record ID: I-CTG-225ac-ac-a9-0642-acd879c5d4 | Not recorded | Not recorded | radioligand-therapy | RECRUITING |
[225Ac]Ac-AKY-1189 (therapeutic)Source studies (1)Record ID: I-CTG-225ac-ac-aky-1189-therapeutic-e092f13cd1 | Not recorded | Not recorded | radioligand-therapy | RECRUITING |
[64Cu]Cu-AKY-1189 (imaging)Source studies (1)Record ID: I-CTG-64cu-cu-aky-1189-imaging-45a8ab64f4 | Not recorded | Not recorded | molecular-imaging-agent | RECRUITING |
[68Ga]Ga-A9-6217Source studies (1)Record ID: I-CTG-68ga-ga-a9-6217-28ce6e0997 | Not recorded | Not recorded | molecular-imaging-agent | RECRUITING |
[68Ga]Ga-NOTA-EPCD6Source studies (1)Record ID: I-CTG-68ga-ga-nota-epcd6-c3b6b40e63 | Not recorded | Not recorded | molecular-imaging-agent | RECRUITING |
[68Ga]Ga-NOTA-RT4Source studies (1)Record ID: I-CTG-68ga-ga-nota-rt4-fdc302ba89 | Not recorded | Not recorded | molecular-imaging-agent | RECRUITING |
A2B530Source studies (1)Record ID: I-CTG-a2b530-dd25994920 | Not recorded | Not recorded | car-t-cell-therapy | ACTIVE_NOT_RECRUITING |
AB122Source studies (1)Record ID: I-CTG-ab122-90ee1bf613 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
AB154Source studies (1)Record ID: I-CTG-ab154-b162427726 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
ABBV-621Source studies (1)Record ID: I-CTG-abbv-621-145a5a1d8e | Not recorded | Not recorded | other-or-unclear | COMPLETED |
AbemaciclibSource studies (1)Record ID: I-CTG-abemaciclib-1354cf6146 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
AbirateroneSource studies (1)Record ID: I-CTG-abiraterone-6f8c767b5d | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Abiraterone AcetateSource studies (1)Record ID: I-CTG-abiraterone-acetate-be32af7aa2 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
AblationSource studies (1)Record ID: I-CTG-ablation-d5288a34c4 | Not recorded | Not recorded | procedure-or-device | COMPLETED |
ABX-EGFSource studies (1)Record ID: I-CTG-abx-egf-dc1ceaee75 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Active surveillanceSource studies (1)Record ID: I-CTG-active-surveillance-4d63f5a6e2 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
ACZ885Source studies (1)Record ID: I-CTG-acz885-94eb7288a5 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
AdenorineSource studies (1)Record ID: I-CTG-adenorine-b88c9ce4cd | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5Source studies (1)Record ID: I-CTG-adenovirus-5-cea-muc1-brachyury-vaccine-tr-871a711d3a | Not recorded | Not recorded | vaccine | ACTIVE_NOT_RECRUITING |
Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRESource studies (1)Record ID: I-CTG-adenovirus-5-f35-human-guanylyl-cyclase-c--cfef342113 | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
Adjuvant chemoradiotherapySource studies (1)Record ID: I-CTG-adjuvant-chemoradiotherapy-4f2ba517df | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING |
adjuvant therapySource studies (1)Record ID: I-CTG-adjuvant-therapy-fa8e84690a | Not recorded | Not recorded | procedure-or-device | COMPLETED |
Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cellSource studies (1)Record ID: I-CTG-adoptive-cell-transfer-of-nkg2dl-targettin-a7524f38de | Not recorded | Not recorded | car-t-cell-therapy | UNKNOWN |
Adoptive ImmunotherapySource studies (1)Record ID: I-CTG-adoptive-immunotherapy-f363a01a06 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Adverse eventSource studies (1)Record ID: I-CTG-adverse-event-0176fffe25 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
AfliberceptSource studies (1)Record ID: I-CTG-aflibercept-0ebf41ec93 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Aflibercept AVE0005Source studies (1)Record ID: I-CTG-aflibercept-ave0005-bd9bb07c15 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
AK104 injectionSource studies (1)Record ID: I-CTG-ak104-injection-212be18ed8 | Not recorded | Not recorded | conventional-cytotoxic-regimen | NOT_YET_RECRUITING |
AldesleukinSource studies (5)Record ID: I-CTG-aldesleukin-953b24ad52 | Not recorded | Not recorded | cellular-therapy | RECRUITING / TERMINATED |
ALT-803Source studies (1)Record ID: I-CTG-alt-803-14dbe0617e | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
ALT803Source studies (1)Record ID: I-CTG-alt803-664ec51b87 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
ALX148Source studies (1)Record ID: I-CTG-alx148-e9f16593fa | Not recorded | Not recorded | other-or-unclear | RECRUITING |
AMG 706Source studies (1)Record ID: I-CTG-amg-706-402c244e95 | Not recorded | inhibitor | small-molecule | COMPLETED |
Aminolevulinic AcidSource studies (1)Record ID: I-CTG-aminolevulinic-acid-26266e8895 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
AmivantamabSource studies (1)Record ID: I-CTG-amivantamab-3efdc81039 | Not recorded | Not recorded | antibody | TERMINATED |
Andes-1537 for InjectionSource studies (1)Record ID: I-CTG-andes-1537-for-injection-95f88580f3 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Anlotinib hydrochloride capsulesSource studies (1)Record ID: I-CTG-anlotinib-hydrochloride-capsules-8604440201 | Not recorded | Not recorded | small-molecule | UNKNOWN |
anti-Kirsten rat sarcoma virus (KRAS) Glycine(G) to Aspartic Acid(D) substitution at codon 12 peripheral blood lymphocytes (PBL)Source studies (1)Record ID: I-CTG-anti-kirsten-rat-sarcoma-virus-kras-glycin-147f0492e0 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Anti-KRAS G12V mTCR PBLSource studies (1)Record ID: I-CTG-anti-kras-g12v-mtcr-pbl-93878ef2b4 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Apatinib Mesylate TabletsSource studies (2)Record ID: I-CTG-apatinib-mesylate-tablets-4e0201acc6 | Not recorded | Not recorded | conventional-cytotoxic-regimen | SUSPENDED / UNKNOWN |
ApheresisSource studies (1)Record ID: I-CTG-apheresis-ed41b65a76 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
AprepitantSource studies (1)Record ID: I-CTG-aprepitant-787ff3ff6c | Not recorded | Not recorded | other-or-unclear | COMPLETED |
artificial intelligence systemSource studies (1)Record ID: I-CTG-artificial-intelligence-system-9c12a4b349 | Not recorded | Not recorded | diagnostic-test | COMPLETED |
ASP1002Source studies (1)Record ID: I-CTG-asp1002-6134c9a134 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
ATRC-101Source studies (1)Record ID: I-CTG-atrc-101-68cdc8775f | Not recorded | Not recorded | antibody | TERMINATED |
autologous dendritic cell vaccinationSource studies (1)Record ID: I-CTG-autologous-dendritic-cell-vaccination-078253425d | Not recorded | Not recorded | vaccine | COMPLETED |
autologous dendritic cells loaded with autologous tumour homogenateSource studies (1)Record ID: I-CTG-autologous-dendritic-cells-loaded-with-aut-0ac8911b52 | Not recorded | Not recorded | vaccine | RECRUITING |
Autologous hematopoietic and immune cell rescue (transplantation)Source studies (1)Record ID: I-CTG-autologous-hematopoietic-and-immune-cell-r-2ddcee3f25 | Not recorded | Not recorded | procedure-or-device | WITHDRAWN |
Autologous tumor cell + CpG vaccineSource studies (1)Record ID: I-CTG-autologous-tumor-cell-cpg-vaccine-75a426cf64 | Not recorded | Not recorded | vaccine | WITHDRAWN |
AZD4635Source studies (1)Record ID: I-CTG-azd4635-ee309fd293 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
BAY 43-9006Source studies (1)Record ID: I-CTG-bay-43-9006-32706741de | Not recorded | Not recorded | other-or-unclear | COMPLETED |
BAY2927088Source studies (1)Record ID: I-CTG-bay2927088-10eedb2ea7 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Best supportive careSource studies (1)Record ID: I-CTG-best-supportive-care-8f032e0c75 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Best Supportive Care (BSC)Source studies (1)Record ID: I-CTG-best-supportive-care-bsc-e0cd284b91 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
BET Bromodomain Inhibitor ZEN-3694Source studies (1)Record ID: I-CTG-bet-bromodomain-inhibitor-zen-3694-3b8be26ce3 | Not recorded | inhibitor | other-or-unclear | RECRUITING |
Bevacizumab + Capecitabine + RadiotherapySource studies (1)Record ID: I-CTG-bevacizumab-capecitabine-radiotherapy-6e5e021cd4 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Bevacizumab in combination with chemotherapy based on fluoropyrimidine IVSource studies (1)Record ID: I-CTG-bevacizumab-in-combination-with-chemothera-9b51bb8bfe | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Bevacizumab injection(Avastin)Source studies (1)Record ID: I-CTG-bevacizumab-injection-avastin-cb4c34f227 | Not recorded | Not recorded | antibody | COMPLETED |
Bevacizumab-containing regimenSource studies (1)Record ID: I-CTG-bevacizumab-containing-regimen-3d791f39a9 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
BIBW 2992Source studies (1)Record ID: I-CTG-bibw-2992-4416ed0aea | Not recorded | Not recorded | other-or-unclear | COMPLETED |
binimetinibSource studies (3)Record ID: I-CTG-binimetinib-fc88a18a7b | Not recorded | Not recorded | other-or-unclear | COMPLETED / TERMINATED / WITHDRAWN |
BiomarkerSource studies (1)Record ID: I-CTG-biomarker-78a06ba58b | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
BiopsySource studies (3)Record ID: I-CTG-biopsy-9621fbc743 | Not recorded | Not recorded | procedure-or-device | COMPLETED / RECRUITING / TERMINATED |
Biopsy ProcedureSource studies (9)Record ID: I-CTG-biopsy-procedure-426e7eb4e9 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING / RECRUITING |
Biospecimen CollectionSource studies (17)Record ID: I-CTG-biospecimen-collection-4197a4ebc7 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING / RECRUITING / TERMINATED / WITHDRAWN |
BLOOD AND TUMORSource studies (1)Record ID: I-CTG-blood-and-tumor-10e5261d4d | Not recorded | Not recorded | procedure-or-device | RECRUITING |
Blood Collection for Plasma ctDNASource studies (1)Record ID: I-CTG-blood-collection-for-plasma-ctdna-c06f923009 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
blood pressure measurementSource studies (1)Record ID: I-CTG-blood-pressure-measurement-e479a7af1e | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Blood sampleSource studies (1)Record ID: I-CTG-blood-sample-c4e8a6bf03 | Not recorded | Not recorded | diagnostic-test | ACTIVE_NOT_RECRUITING |
Blood samplingSource studies (1)Record ID: I-CTG-blood-sampling-8397318160 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Blood testSource studies (1)Record ID: I-CTG-blood-test-b2571e0e22 | Not recorded | Not recorded | cellular-therapy | COMPLETED |
Bone Marrow BiopsySource studies (1)Record ID: I-CTG-bone-marrow-biopsy-d361d304aa | Not recorded | Not recorded | procedure-or-device | TERMINATED |
Bone ScanSource studies (1)Record ID: I-CTG-bone-scan-76e68ecb1f | Not recorded | Not recorded | procedure-or-device | RECRUITING |
BortezomibSource studies (1)Record ID: I-CTG-bortezomib-080fc3cced | Not recorded | Not recorded | conventional-cytotoxic-regimen | UNKNOWN |
BTG-002814Source studies (1)Record ID: I-CTG-btg-002814-7ade8f054d | Not recorded | Not recorded | other-or-unclear | COMPLETED |
BVAC-BSource studies (1)Record ID: I-CTG-bvac-b-af1d5fe703 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
BW and heightSource studies (1)Record ID: I-CTG-bw-and-height-f41a2fad6d | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
BYL719Source studies (1)Record ID: I-CTG-byl719-94ba9da64b | Not recorded | Not recorded | other-or-unclear | COMPLETED |
CabozantinibSource studies (1)Record ID: I-CTG-cabozantinib-c1202a0fd8 | Not recorded | binder; inhibitor | other-or-unclear | ACTIVE_NOT_RECRUITING |
CAdVECSource studies (1)Record ID: I-CTG-cadvec-b1e763cb1d | Not recorded | Not recorded | other-or-unclear | RECRUITING |
cancer stem cell vaccineSource studies (1)Record ID: I-CTG-cancer-stem-cell-vaccine-c02a83eda3 | Not recorded | Not recorded | vaccine | COMPLETED |
CannabidiolSource studies (1)Record ID: I-CTG-cannabidiol-763c603576 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
capecitabineSource studies (21)Record ID: I-CTG-capecitabine-c72c76a9c0 | Not recorded | Not recorded | conventional-cytotoxic-regimen | ACTIVE_NOT_RECRUITING / COMPLETED / NOT_YET_RECRUITING / RECRUITING / TERMINATED / UNKNOWN / WITHDRAWN |
Capecitabine + RadiotherapySource studies (1)Record ID: I-CTG-capecitabine-radiotherapy-b30419b255 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
CapeOxSource studies (1)Record ID: I-CTG-capeox-aa8e491416 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
capillaroscopySource studies (1)Record ID: I-CTG-capillaroscopy-2022d7eaf9 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
CAR-T cellSource studies (1)Record ID: I-CTG-car-t-cell-14e8e8d819 | Not recorded | Not recorded | car-t-cell-therapy | UNKNOWN |
CarboplatinSource studies (7)Record ID: I-CTG-carboplatin-fcaf0e1c36 | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING / TERMINATED |
Carboplatin + Pemetrexed + PembrolizumabSource studies (1)Record ID: I-CTG-carboplatin-pemetrexed-pembrolizumab-bfcbee9719 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
CEA-loaded dendritic cell vaccineSource studies (1)Record ID: I-CTG-cea-loaded-dendritic-cell-vaccine-88a88d2400 | Not recorded | Not recorded | vaccine | COMPLETED |
CediranibSource studies (1)Record ID: I-CTG-cediranib-2c3f197078 | Not recorded | binder; inhibitor | small-molecule | ACTIVE_NOT_RECRUITING |
CelecoxibSource studies (1)Record ID: I-CTG-celecoxib-de59c17075 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
CemiplimabSource studies (1)Record ID: I-CTG-cemiplimab-21fb1ce506 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
cemiplimab + REGN7075Source studies (1)Record ID: I-CTG-cemiplimab-regn7075-229dd94a54 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
cemiplimab plus fianlimabSource studies (1)Record ID: I-CTG-cemiplimab-plus-fianlimab-273c96b045 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Cetuximab (Erbitux)Source studies (1)Record ID: I-CTG-cetuximab-erbitux-a5910d5bf7 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
cetuximab and lapatinibSource studies (1)Record ID: I-CTG-cetuximab-and-lapatinib-92aa5f1a93 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Cetuximab and Radiation TherapySource studies (1)Record ID: I-CTG-cetuximab-and-radiation-therapy-2fd470462b | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
Cetuximab injectionSource studies (1)Record ID: I-CTG-cetuximab-injection-49d9830a2d | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Cetuximab, irinotecanSource studies (1)Record ID: I-CTG-cetuximab-irinotecan-3bb2b8cb08 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Cetuximab/Gefitinib combination and/or monotherapySource studies (1)Record ID: I-CTG-cetuximab-gefitinib-combination-and-or-mon-c7431b06f0 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Checkpoint inhibitor (CPI) such as Pembrolizumab plus chemotherapySource studies (1)Record ID: I-CTG-checkpoint-inhibitor-cpi-such-as-pembroliz-b7de134724 | Not recorded | inhibitor | conventional-cytotoxic-regimen | RECRUITING |
Chemoradiotherapy plus BevacizumabSource studies (1)Record ID: I-CTG-chemoradiotherapy-plus-bevacizumab-4cc222d1f2 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
ChemotherapySource studies (3)Record ID: I-CTG-chemotherapy-ec0f3b0bd1 | Not recorded | Not recorded | conventional-cytotoxic-regimen | ACTIVE_NOT_RECRUITING / COMPLETED / UNKNOWN |
Chemotherapy DrugsSource studies (1)Record ID: I-CTG-chemotherapy-drugs-94ae93efe0 | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING |
chemotherapy in combination with trastuzumab for arm1Source studies (1)Record ID: I-CTG-chemotherapy-in-combination-with-trastuzum-1a4b4db3d3 | Not recorded | Not recorded | conventional-cytotoxic-regimen | UNKNOWN |
chemotherapy in combination with trastuzumab for arm2Source studies (1)Record ID: I-CTG-chemotherapy-in-combination-with-trastuzum-18646cd401 | Not recorded | Not recorded | conventional-cytotoxic-regimen | UNKNOWN |
chemotherapy in combination with trastuzumab for arm3Source studies (1)Record ID: I-CTG-chemotherapy-in-combination-with-trastuzum-b750fc0438 | Not recorded | Not recorded | conventional-cytotoxic-regimen | UNKNOWN |
chemotherapy in combination with trastuzumab for arm4Source studies (1)Record ID: I-CTG-chemotherapy-in-combination-with-trastuzum-0327251cbb | Not recorded | Not recorded | conventional-cytotoxic-regimen | UNKNOWN |
chemotherapy plus bevacizumabSource studies (1)Record ID: I-CTG-chemotherapy-plus-bevacizumab-fa81e187f1 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Chest x-raySource studies (1)Record ID: I-CTG-chest-x-ray-3fa98eebe0 | Not recorded | Not recorded | diagnostic-test | TERMINATED |
ChromoendoscopySource studies (1)Record ID: I-CTG-chromoendoscopy-af0875c463 | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
CibisatamabSource studies (1)Record ID: I-CTG-cibisatamab-7c89498bdb | Not recorded | Not recorded | other-or-unclear | TERMINATED |
CisplatinSource studies (2)Record ID: I-CTG-cisplatin-8114f85e2a | Not recorded | Not recorded | other-or-unclear | RECRUITING |
CJM112Source studies (1)Record ID: I-CTG-cjm112-5dfdfeda68 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Clostridium butyricumSource studies (1)Record ID: I-CTG-clostridium-butyricum-c2370b6d03 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
CM-24 (MK-6018)Source studies (1)Record ID: I-CTG-cm-24-mk-6018-f0ba3f9e9f | Not recorded | Not recorded | antibody | TERMINATED |
CMAB009Source studies (1)Record ID: I-CTG-cmab009-ed1299fc41 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
CNA3103: 1.5 x 10^8 cellsSource studies (1)Record ID: I-CTG-cna3103-1-5-x-10-8-cells-77927f9de8 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
CNA3103: 1.5 x 10^9 cellsSource studies (1)Record ID: I-CTG-cna3103-1-5-x-10-9-cells-7b8c8a35bf | Not recorded | Not recorded | other-or-unclear | RECRUITING |
CNA3103: 2.5 x 10^7 cellsSource studies (1)Record ID: I-CTG-cna3103-2-5-x-10-7-cells-39766e37d3 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
CNA3103: 4.5 x 10^8 cellsSource studies (1)Record ID: I-CTG-cna3103-4-5-x-10-8-cells-b238ca48c9 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
CNA3103: 5 x 10^7 cellsSource studies (1)Record ID: I-CTG-cna3103-5-x-10-7-cells-ed12107ac1 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
CNA3103: 6.75 × 10^8 cellsSource studies (1)Record ID: I-CTG-cna3103-6-75-10-8-cells-4f68dfa5a1 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
CobimetinibSource studies (1)Record ID: I-CTG-cobimetinib-da77e494cc | Not recorded | Not recorded | other-or-unclear | COMPLETED |
ColectomySource studies (1)Record ID: I-CTG-colectomy-8a2d7bf2fb | Not recorded | Not recorded | procedure-or-device | RECRUITING |
ColonoscopySource studies (1)Record ID: I-CTG-colonoscopy-255c6f3995 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
Colonoscopy with Retroview scope combing forward and retroflexed withdrawal techniqueSource studies (1)Record ID: I-CTG-colonoscopy-with-retroview-scope-combing-f-e77e031f92 | Not recorded | Not recorded | diagnostic-test | COMPLETED |
Colonoscopy with standard colonoscope and forward withdrawal techniqueSource studies (1)Record ID: I-CTG-colonoscopy-with-standard-colonoscope-and--f34c8cebcc | Not recorded | Not recorded | diagnostic-test | COMPLETED |
Colorectal cancer proceduresSource studies (1)Record ID: I-CTG-colorectal-cancer-procedures-bfa4f087aa | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
Colorectal surgery (resection)Source studies (1)Record ID: I-CTG-colorectal-surgery-resection-805dd62c05 | Not recorded | Not recorded | procedure-or-device | COMPLETED |
COM701Source studies (1)Record ID: I-CTG-com701-eb74d629d9 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
COM701 with Opdivo (Nivolumab).Source studies (1)Record ID: I-CTG-com701-with-opdivo-nivolumab-e3d14f4c17 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Combination Therapy: PY314 + PembrolizumabSource studies (1)Record ID: I-CTG-combination-therapy-py314-pembrolizumab-397f9f194b | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Computed TomographySource studies (17)Record ID: I-CTG-computed-tomography-d4953cd85e | Not recorded | Not recorded | molecular-imaging-agent | ACTIVE_NOT_RECRUITING / ENROLLING_BY_INVITATION / RECRUITING / TERMINATED |
Computer-aided diagnosis (CADx) support toolSource studies (1)Record ID: I-CTG-computer-aided-diagnosis-cadx-support-tool-3c1ea5a6ea | Not recorded | Not recorded | diagnostic-test | COMPLETED |
ConatumumabSource studies (1)Record ID: I-CTG-conatumumab-1002c2336a | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Confocal endomicroscopySource studies (1)Record ID: I-CTG-confocal-endomicroscopy-6af8f1b27c | Not recorded | Not recorded | procedure-or-device | COMPLETED |
Confocal laser endomicroscopy (CLE)Source studies (1)Record ID: I-CTG-confocal-laser-endomicroscopy-cle-a7feb51e6c | Not recorded | Not recorded | procedure-or-device | UNKNOWN |
Continuous hyperthermic peritoneal perfusion (CHPP) with CisplatinSource studies (1)Record ID: I-CTG-continuous-hyperthermic-peritoneal-perfusi-7542d19b4a | Not recorded | Not recorded | procedure-or-device | COMPLETED |
Contrasting CTSource studies (1)Record ID: I-CTG-contrasting-ct-f6ec36a18e | Not recorded | Not recorded | radiation | UNKNOWN |
Control groupSource studies (1)Record ID: I-CTG-control-group-bfb83ec17b | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING |
conventional surgerySource studies (1)Record ID: I-CTG-conventional-surgery-983550c6c0 | Not recorded | Not recorded | procedure-or-device | COMPLETED |
CP-675,206Source studies (1)Record ID: I-CTG-cp-675-206-a32de41159 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
CPGJ602Source studies (1)Record ID: I-CTG-cpgj602-8f9c6c2f70 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
CPI-006 + ciforadenantSource studies (1)Record ID: I-CTG-cpi-006-ciforadenant-c153076cc2 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
CPI-006 + pembrolizumabSource studies (1)Record ID: I-CTG-cpi-006-pembrolizumab-3ab6f2ce6c | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Creatinine clearanceSource studies (1)Record ID: I-CTG-creatinine-clearance-18461fe2a0 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
Crisaborole OintmentSource studies (1)Record ID: I-CTG-crisaborole-ointment-f6a3fcb92f | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
CTSource studies (1)Record ID: I-CTG-ct-f8dcb34308 | Not recorded | Not recorded | diagnostic-test | TERMINATED |
CT scanSource studies (1)Record ID: I-CTG-ct-scan-25e54eb278 | Not recorded | Not recorded | diagnostic-test | COMPLETED |
ctDNA methylation dynamic monitoringSource studies (1)Record ID: I-CTG-ctdna-methylation-dynamic-monitoring-e78a5899f0 | Not recorded | Not recorded | diagnostic-test | RECRUITING |
ctDNA Mutation Analysis via ddPCRSource studies (1)Record ID: I-CTG-ctdna-mutation-analysis-via-ddpcr-158cc851ac | Not recorded | Not recorded | diagnostic-test | RECRUITING |
ctDNA testingSource studies (1)Record ID: I-CTG-ctdna-testing-188082d0ed | Not recorded | Not recorded | other-or-unclear | RECRUITING |
CV301Source studies (1)Record ID: I-CTG-cv301-53b7453e29 | Not recorded | Not recorded | vaccine | COMPLETED |
CYAD-101Source studies (2)Record ID: I-CTG-cyad-101-869368c463 | Not recorded | Not recorded | car-t-cell-therapy | RECRUITING |
CyclophosphamideSource studies (10)Record ID: I-CTG-cyclophosphamide-f8f5717419 | Not recorded | Not recorded | other-or-unclear | RECRUITING / TERMINATED / WITHDRAWN |
DacogenTM (decitabine)Source studies (1)Record ID: I-CTG-dacogentm-decitabine-1b1d831e14 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Dalotuzumab 10 mg/kgSource studies (1)Record ID: I-CTG-dalotuzumab-10-mg-kg-73403e9c09 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Dalotuzumab 15/7.5 mg/kgSource studies (1)Record ID: I-CTG-dalotuzumab-15-7-5-mg-kg-cb2902ab21 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
DDI Probe CocktailSource studies (1)Record ID: I-CTG-ddi-probe-cocktail-1ab21be774 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
DEBIRISource studies (1)Record ID: I-CTG-debiri-90728d2685 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
DecitabineSource studies (1)Record ID: I-CTG-decitabine-44e1b32827 | Not recorded | Not recorded | other-or-unclear | NOT_YET_RECRUITING |
Decoy20Source studies (1)Record ID: I-CTG-decoy20-942a6c91bd | Not recorded | agonist | other-or-unclear | ACTIVE_NOT_RECRUITING |
Dendritic Cell VaccineSource studies (1)Record ID: I-CTG-dendritic-cell-vaccine-40ced16617 | Not recorded | Not recorded | vaccine | COMPLETED |
Dendritic cells vaccineSource studies (1)Record ID: I-CTG-dendritic-cells-vaccine-e87c5fcd01 | Not recorded | Not recorded | vaccine | UNKNOWN |
denileukin diftitoxSource studies (1)Record ID: I-CTG-denileukin-diftitox-1d79e88212 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Digital Rectal ExaminationSource studies (1)Record ID: I-CTG-digital-rectal-examination-382bc63c95 | Not recorded | Not recorded | procedure-or-device | RECRUITING |
Diphenhydramine hydrochloride (HCl)Source studies (1)Record ID: I-CTG-diphenhydramine-hydrochloride-hcl-c1cd720f4e | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Diphtheria/Tetanus VaccineSource studies (1)Record ID: I-CTG-diphtheria-tetanus-vaccine-155e5d9925 | Not recorded | Not recorded | vaccine | TERMINATED |
DISP-10Source studies (1)Record ID: I-CTG-disp-10-89d47f9270 | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING |
DivarasibSource studies (1)Record ID: I-CTG-divarasib-396157f6b6 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
DocetaxelSource studies (3)Record ID: I-CTG-docetaxel-1ad915ad9e | Not recorded | Not recorded | other-or-unclear | COMPLETED / RECRUITING |
Docetaxel (Taxotere)Source studies (1)Record ID: I-CTG-docetaxel-taxotere-168b0a7cb0 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
DostarlimabSource studies (1)Record ID: I-CTG-dostarlimab-b72c71f530 | Not recorded | Not recorded | antibody | COMPLETED |
DS-8201aSource studies (1)Record ID: I-CTG-ds-8201a-cf25a7a751 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
DS-8201a 5.4 mg/kg Q3WSource studies (1)Record ID: I-CTG-ds-8201a-5-4-mg-kg-q3w-e5805da10c | Not recorded | Not recorded | other-or-unclear | COMPLETED |
DS-8201a 6.4 mg/kg Q3WSource studies (1)Record ID: I-CTG-ds-8201a-6-4-mg-kg-q3w-df2034b62f | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Dual-Target Antigen-Selected CAR-NKSource studies (1)Record ID: I-CTG-dual-target-antigen-selected-car-nk-c69960a6a1 | Not recorded | Not recorded | car-nk-cell-therapy | RECRUITING |
Dye-Based ChromoendoscopySource studies (1)Record ID: I-CTG-dye-based-chromoendoscopy-dd57846283 | Not recorded | Not recorded | procedure-or-device | NOT_YET_RECRUITING |
E7 TCR-T cellsSource studies (2)Record ID: I-CTG-e7-tcr-t-cells-28141aa90b | Not recorded | Not recorded | cellular-therapy | RECRUITING |
E7046Source studies (1)Record ID: I-CTG-e7046-9a933e04a4 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
EB-SELECT Single-Target CAR-NK CellsSource studies (1)Record ID: I-CTG-eb-select-single-target-car-nk-cells-f1020c8ad8 | Not recorded | Not recorded | car-nk-cell-therapy | RECRUITING |
Echocardiography TestSource studies (3)Record ID: I-CTG-echocardiography-test-b5bb6dc083 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING / RECRUITING |
Educational InterventionSource studies (1)Record ID: I-CTG-educational-intervention-90963afc6d | Not recorded | Not recorded | other-or-unclear | RECRUITING |
EGF816Source studies (1)Record ID: I-CTG-egf816-65942cfc88 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
EKGSource studies (1)Record ID: I-CTG-ekg-1518c8fdc6 | Not recorded | Not recorded | diagnostic-test | TERMINATED |
Electronic Health Record ReviewSource studies (2)Record ID: I-CTG-electronic-health-record-review-58bf833df3 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
ELI-002 7PSource studies (1)Record ID: I-CTG-eli-002-7p-1fc1f11779 | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
EmavusertibSource studies (1)Record ID: I-CTG-emavusertib-198f10d92d | Not recorded | Not recorded | other-or-unclear | RECRUITING |
EMB-01Source studies (1)Record ID: I-CTG-emb-01-c55ad0eb9b | Not recorded | Not recorded | bispecific-antibody | NOT_YET_RECRUITING |
EMI-137Source studies (1)Record ID: I-CTG-emi-137-5c73a8f0cd | Not recorded | Not recorded | other-or-unclear | COMPLETED |
encorafenibSource studies (1)Record ID: I-CTG-encorafenib-66cf055d05 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
endocytoscopySource studies (1)Record ID: I-CTG-endocytoscopy-a0b76fa672 | Not recorded | Not recorded | diagnostic-test | COMPLETED |
EndoscopeSource studies (1)Record ID: I-CTG-endoscope-8590d2a265 | Not recorded | Not recorded | procedure-or-device | RECRUITING |
Endoscopic ProcedureSource studies (1)Record ID: I-CTG-endoscopic-procedure-8af6485519 | Not recorded | Not recorded | procedure-or-device | RECRUITING |
EndoscopySource studies (1)Record ID: I-CTG-endoscopy-14a417830e | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
EnzalutamideSource studies (3)Record ID: I-CTG-enzalutamide-02d130d71a | Not recorded | Not recorded | other-or-unclear | COMPLETED / RECRUITING / TERMINATED |
EO2040Source studies (1)Record ID: I-CTG-eo2040-1f62e48b14 | Not recorded | Not recorded | vaccine | TERMINATED |
epiduralSource studies (1)Record ID: I-CTG-epidural-864413e5bb | Not recorded | Not recorded | procedure-or-device | UNKNOWN |
ErlotinibSource studies (1)Record ID: I-CTG-erlotinib-fa6bba6f28 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
erlotinib hydrochlorideSource studies (2)Record ID: I-CTG-erlotinib-hydrochloride-25091918cd | Not recorded | Not recorded | other-or-unclear | COMPLETED |
ETBX-011Source studies (1)Record ID: I-CTG-etbx-011-51ede04218 | Not recorded | Not recorded | vaccine | WITHDRAWN |
ETBX-021Source studies (1)Record ID: I-CTG-etbx-021-adeeb90c9f | Not recorded | Not recorded | vaccine | WITHDRAWN |
ETBX-051Source studies (1)Record ID: I-CTG-etbx-051-c8adc785a4 | Not recorded | Not recorded | vaccine | WITHDRAWN |
ETBX-061Source studies (1)Record ID: I-CTG-etbx-061-20b1a51bf2 | Not recorded | Not recorded | vaccine | WITHDRAWN |
Experimental GroupSource studies (1)Record ID: I-CTG-experimental-group-ee3e8ab9d9 | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING |
Experimental: COLONYVAQ-CRC + mFOLFOX6 or CAPOX + NivolumabSource studies (1)Record ID: I-CTG-experimental-colonyvaq-crc-mfolfox6-or-cap-5487896cc8 | Not recorded | Not recorded | vaccine | RECRUITING |
Extension HER-2 vaccine trial at OBDSource studies (1)Record ID: I-CTG-extension-her-2-vaccine-trial-at-obd-755266448d | Not recorded | Not recorded | vaccine | COMPLETED |
F-18 16 Alpha-FluoroestradiolSource studies (1)Record ID: I-CTG-f-18-16-alpha-fluoroestradiol-131fc1e46a | Not recorded | Not recorded | molecular-imaging-agent | TERMINATED |
Faecal Immunochemical TestSource studies (1)Record ID: I-CTG-faecal-immunochemical-test-5870f968de | Not recorded | Not recorded | diagnostic-test | UNKNOWN |
Fam-Trastuzumab Deruxtecan-NxkiSource studies (1)Record ID: I-CTG-fam-trastuzumab-deruxtecan-nxki-f9be2eb3a8 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
FATE-NK100Source studies (1)Record ID: I-CTG-fate-nk100-41bd5322f7 | Not recorded | Not recorded | cellular-therapy | COMPLETED |
Flow cytometrySource studies (1)Record ID: I-CTG-flow-cytometry-0e267cdbea | Not recorded | Not recorded | other-or-unclear | NOT_YET_RECRUITING |
FLOX (5-fluorouracil and folinic acid and oxaliplatin) intermittently and maintenance cetuximabSource studies (1)Record ID: I-CTG-flox-5-fluorouracil-and-folinic-acid-and-o-3b6c9dadca | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
FLOX (5-fluorouracil/folinic acid/oxaliplatin)Source studies (1)Record ID: I-CTG-flox-5-fluorouracil-folinic-acid-oxaliplat-d728562dd9 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
FLOX (5-fluorouracil/folinic acid/oxaliplatin) and CetuximabSource studies (1)Record ID: I-CTG-flox-5-fluorouracil-folinic-acid-oxaliplat-a4c08af5e7 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
FludarabineSource studies (6)Record ID: I-CTG-fludarabine-cb9905f3e0 | Not recorded | Not recorded | other-or-unclear | RECRUITING / TERMINATED |
Fluorescence-Guided SurgerySource studies (1)Record ID: I-CTG-fluorescence-guided-surgery-00a8f26f44 | Not recorded | Not recorded | procedure-or-device | RECRUITING |
Fluoropyrimidine (5-FU/LV or capecitabine)Source studies (1)Record ID: I-CTG-fluoropyrimidine-5-fu-lv-or-capecitabine-d8b0b970a1 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
fluorouracilSource studies (15)Record ID: I-CTG-fluorouracil-9095bd0841 | Not recorded | Not recorded | conventional-cytotoxic-regimen | ACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED / UNKNOWN |
Fluorouracil (5-FU)Source studies (1)Record ID: I-CTG-fluorouracil-5-fu-e06666de0c | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
FOLFIRISource studies (12)Record ID: I-CTG-folfiri-35fc3df147 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED / NOT_YET_RECRUITING / RECRUITING / TERMINATED |
FOLFIRI (5-Fluorouracil, Folinic acid, Irinotecan)Source studies (1)Record ID: I-CTG-folfiri-5-fluorouracil-folinic-acid-irinot-2b114c7db7 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
FOLFIRI + CetuximabSource studies (2)Record ID: I-CTG-folfiri-cetuximab-860059a0ea | Not recorded | Not recorded | antibody | UNKNOWN |
FOLFIRI ProtocolSource studies (3)Record ID: I-CTG-folfiri-protocol-7d8f4e05f8 | Not recorded | Not recorded | conventional-cytotoxic-regimen | ACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING |
FOLFIRI regimenSource studies (1)Record ID: I-CTG-folfiri-regimen-c607e2b8f0 | Not recorded | Not recorded | conventional-cytotoxic-regimen | TERMINATED |
Folfiri/CetuximabSource studies (1)Record ID: I-CTG-folfiri-cetuximab-4796e99102 | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING |
FOLFOXSource studies (3)Record ID: I-CTG-folfox-d34f6ef74e | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING |
FOLFOX 6Source studies (1)Record ID: I-CTG-folfox-6-e0fad68f21 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
FOLFOX induction regimenSource studies (1)Record ID: I-CTG-folfox-induction-regimen-9bade73465 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
FOLFOX regimenSource studies (4)Record ID: I-CTG-folfox-regimen-ea3401d06d | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED / TERMINATED / UNKNOWN |
FOLFOX-4Source studies (1)Record ID: I-CTG-folfox-4-d040833f0b | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
FOLFOXIRI plus BevacizumabSource studies (1)Record ID: I-CTG-folfoxiri-plus-bevacizumab-364286467b | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Folic acidSource studies (2)Record ID: I-CTG-folic-acid-501412629a | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
Folinic acidSource studies (4)Record ID: I-CTG-folinic-acid-555688dff7 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED / RECRUITING / UNKNOWN |
folinic acid/5-FU/oxaliplatin (mFOLFOX-6)Source studies (1)Record ID: I-CTG-folinic-acid-5-fu-oxaliplatin-mfolfox-6-f63a4d8e1f | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
FoundationOne®Liquid CDxSource studies (1)Record ID: I-CTG-foundationoneliquid-cdx-f5f2d66cf0 | Not recorded | Not recorded | diagnostic-test | RECRUITING |
FPI-2053Source studies (1)Record ID: I-CTG-fpi-2053-a6fb70a89b | Not recorded | Not recorded | bispecific-antibody | ACTIVE_NOT_RECRUITING |
FT536Source studies (1)Record ID: I-CTG-ft536-68cc3bb06f | Not recorded | Not recorded | other-or-unclear | TERMINATED |
fulvestrantSource studies (3)Record ID: I-CTG-fulvestrant-45c4801d03 | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING / RECRUITING / WITHDRAWN |
FutuximabSource studies (1)Record ID: I-CTG-futuximab-083f8ace97 | Not recorded | Not recorded | antibody | TERMINATED |
G17DT-IrinotecanSource studies (1)Record ID: I-CTG-g17dt-irinotecan-112db7bbf1 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Ga-68-FAPI-46Source studies (1)Record ID: I-CTG-ga-68-fapi-46-53a9f71020 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Gallium Ga 68 FAPi-46Source studies (1)Record ID: I-CTG-gallium-ga-68-fapi-46-15339208a2 | Not recorded | Not recorded | radiation | ACTIVE_NOT_RECRUITING |
Gallium Ga 68-labeled PSMA-11Source studies (1)Record ID: I-CTG-gallium-ga-68-labeled-psma-11-9bb7e663d2 | Not recorded | Not recorded | radiation | ACTIVE_NOT_RECRUITING |
Gamma-Secretase Inhibitor RO4929097Source studies (1)Record ID: I-CTG-gamma-secretase-inhibitor-ro4929097-1775af3aa6 | Not recorded | inhibitor | other-or-unclear | TERMINATED |
GardasilSource studies (1)Record ID: I-CTG-gardasil-16ee4fb02f | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
GemcitabineSource studies (3)Record ID: I-CTG-gemcitabine-cb0f740757 | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING / UNKNOWN |
Gemcitabine + Nab-paclitaxelSource studies (1)Record ID: I-CTG-gemcitabine-nab-paclitaxel-7dd4208c30 | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING |
Gene Modified T CellsSource studies (2)Record ID: I-CTG-gene-modified-t-cells-fc791108b3 | Not recorded | Not recorded | cellular-therapy | SUSPENDED / TERMINATED |
GI-4000Source studies (1)Record ID: I-CTG-gi-4000-8114732f91 | Not recorded | Not recorded | vaccine | WITHDRAWN |
GI-6207Source studies (1)Record ID: I-CTG-gi-6207-a3bf2bdcf9 | Not recorded | Not recorded | vaccine | WITHDRAWN |
GI-6301Source studies (1)Record ID: I-CTG-gi-6301-7ace324b92 | Not recorded | Not recorded | vaccine | WITHDRAWN |
Glycosylated Recombinant Human Interleukin-7Source studies (1)Record ID: I-CTG-glycosylated-recombinant-human-interleukin-22e6df37bf | Not recorded | Not recorded | other-or-unclear | TERMINATED |
GM-CT-01 plus 5-FluorouracilSource studies (1)Record ID: I-CTG-gm-ct-01-plus-5-fluorouracil-d4bb5b655a | Not recorded | Not recorded | conventional-cytotoxic-regimen | TERMINATED |
GM102Source studies (1)Record ID: I-CTG-gm102-28e316180e | Not recorded | Not recorded | other-or-unclear | COMPLETED |
GM102 expansionSource studies (1)Record ID: I-CTG-gm102-expansion-a5fb9bace4 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
GSK5764227Source studies (1)Record ID: I-CTG-gsk5764227-624456bca2 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
haNKSource studies (1)Record ID: I-CTG-hank-0a99b793f4 | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
HBs antibody and HBc antibodySource studies (1)Record ID: I-CTG-hbs-antibody-and-hbc-antibody-f4b0725ed8 | Not recorded | Not recorded | antibody | UNKNOWN |
HBs antigen and HCV antibodySource studies (1)Record ID: I-CTG-hbs-antigen-and-hcv-antibody-c0e3aee1da | Not recorded | Not recorded | antibody | UNKNOWN |
HD ColonSource studies (2)Record ID: I-CTG-hd-colon-d1daf5e764 | Not recorded | Not recorded | procedure-or-device | COMPLETED / UNKNOWN |
Hepatitis A VaccineSource studies (1)Record ID: I-CTG-hepatitis-a-vaccine-9cc9cd5d2c | Not recorded | Not recorded | vaccine | TERMINATED |
Hepatitis B VaccineSource studies (1)Record ID: I-CTG-hepatitis-b-vaccine-04776562f0 | Not recorded | Not recorded | vaccine | TERMINATED |
HER-2 vaccineSource studies (1)Record ID: I-CTG-her-2-vaccine-0f2c831000 | Not recorded | Not recorded | vaccine | COMPLETED |
High definition white light endoscopySource studies (1)Record ID: I-CTG-high-definition-white-light-endoscopy-6d4580e861 | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
High Definition White Light EndosocopySource studies (1)Record ID: I-CTG-high-definition-white-light-endosocopy-14d56656d6 | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
HIPECSource studies (1)Record ID: I-CTG-hipec-cefb483ae4 | Not recorded | Not recorded | procedure-or-device | COMPLETED |
HMBD-001Source studies (1)Record ID: I-CTG-hmbd-001-a5fb342724 | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
HMBD-001 and enzalutamideSource studies (1)Record ID: I-CTG-hmbd-001-and-enzalutamide-acde4f5f43 | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
huA33Source studies (1)Record ID: I-CTG-hua33-7320a578ae | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Huaier granuleSource studies (1)Record ID: I-CTG-huaier-granule-22f248c6e6 | Not recorded | Not recorded | other-or-unclear | NOT_YET_RECRUITING |
HuC242-DM4Source studies (1)Record ID: I-CTG-huc242-dm4-fbf428acab | Not recorded | Not recorded | other-or-unclear | COMPLETED |
I-Scan 1Source studies (2)Record ID: I-CTG-i-scan-1-767b38fc5b | Not recorded | Not recorded | procedure-or-device | COMPLETED / UNKNOWN |
I-Scan 2Source studies (2)Record ID: I-CTG-i-scan-2-85eb2b3764 | Not recorded | Not recorded | procedure-or-device | COMPLETED / UNKNOWN |
i-scan CE, SE, TE modeSource studies (1)Record ID: I-CTG-i-scan-ce-se-te-mode-64102b4db8 | Not recorded | Not recorded | procedure-or-device | COMPLETED |
ICGSource studies (1)Record ID: I-CTG-icg-183a746658 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
IKS04 antibody drug conjugate ADC + Isumab04 monoclonal antibodySource studies (1)Record ID: I-CTG-iks04-antibody-drug-conjugate-adc-isumab04-99f7e1dc77 | Not recorded | cytotoxic-payload-delivery | antibody-drug-conjugate | NOT_YET_RECRUITING |
IL-2Source studies (2)Record ID: I-CTG-il-2-2f861543e7 | Not recorded | Not recorded | antibody | SUSPENDED / TERMINATED |
IL2Source studies (1)Record ID: I-CTG-il2-839489f4fd | Not recorded | Not recorded | vaccine | RECRUITING |
Imaging studySource studies (1)Record ID: I-CTG-imaging-study-ce73d4d01a | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Imaging TechniqueSource studies (1)Record ID: I-CTG-imaging-technique-b81c2ffbd9 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
Imatinib mesylate and panitumumabSource studies (1)Record ID: I-CTG-imatinib-mesylate-and-panitumumab-19db40f9ca | Not recorded | Not recorded | other-or-unclear | COMPLETED |
IMC-A12Source studies (1)Record ID: I-CTG-imc-a12-68ed666b05 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
IMC-A12 (cixutumumab)Source studies (1)Record ID: I-CTG-imc-a12-cixutumumab-14d748b189 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
ImiquimodSource studies (1)Record ID: I-CTG-imiquimod-ab6fc72dae | Not recorded | Not recorded | other-or-unclear | ENROLLING_BY_INVITATION |
ImmunohistochemistrySource studies (1)Record ID: I-CTG-immunohistochemistry-e5a00a7d8d | Not recorded | Not recorded | diagnostic-test | COMPLETED |
Immunohistochemistry or immunofluorescenceSource studies (1)Record ID: I-CTG-immunohistochemistry-or-immunofluorescence-4e7605b331 | Not recorded | Not recorded | other-or-unclear | NOT_YET_RECRUITING |
Immunotherapeutic AgentsSource studies (1)Record ID: I-CTG-immunotherapeutic-agents-d86db01d18 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
ImmunotherapySource studies (2)Record ID: I-CTG-immunotherapy-f3bf3779cf | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING / RECRUITING |
IMO-2055Source studies (1)Record ID: I-CTG-imo-2055-35cf7400a8 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Impact of Gender on Davinci rectal surgerySource studies (1)Record ID: I-CTG-impact-of-gender-on-davinci-rectal-surgery-4282ba07bc | Not recorded | Not recorded | procedure-or-device | COMPLETED |
IMT-009Source studies (1)Record ID: I-CTG-imt-009-1ad49d3434 | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
InavolisibSource studies (1)Record ID: I-CTG-inavolisib-3eae227893 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
INCAGN01876Source studies (1)Record ID: I-CTG-incagn01876-21ea5e3fa0 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Indium labeled IMP-205xm734Source studies (1)Record ID: I-CTG-indium-labeled-imp-205xm734-fdb1ad65c0 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
INT230-6Source studies (1)Record ID: I-CTG-int230-6-3bc32b436c | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Interleukin-2Source studies (1)Record ID: I-CTG-interleukin-2-531a829bc6 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Internet-Based InterventionSource studies (1)Record ID: I-CTG-internet-based-intervention-a8c0566a46 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Iodine I 124 Monoclonal Antibody M5ASource studies (1)Record ID: I-CTG-iodine-i-124-monoclonal-antibody-m5a-3d0b190b93 | Not recorded | Not recorded | molecular-imaging-agent | COMPLETED |
IrinotecanSource studies (20)Record ID: I-CTG-irinotecan-3298e18a64 | Not recorded | Not recorded | conventional-cytotoxic-regimen | ACTIVE_NOT_RECRUITING / COMPLETED / NOT_YET_RECRUITING / RECRUITING / TERMINATED / UNKNOWN / WITHDRAWN |
Irinotecan (Camptosar)Source studies (1)Record ID: I-CTG-irinotecan-camptosar-ed020bb67e | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING |
irinotecan hydrochlorideSource studies (7)Record ID: I-CTG-irinotecan-hydrochloride-cd73034bfe | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED / TERMINATED |
ItraconazoleSource studies (1)Record ID: I-CTG-itraconazole-25098b221a | Not recorded | Not recorded | other-or-unclear | RECRUITING |
IX001 TCR-T cellsSource studies (1)Record ID: I-CTG-ix001-tcr-t-cells-520199426c | Not recorded | Not recorded | cellular-therapy | WITHDRAWN |
JAB-3312Source studies (2)Record ID: I-CTG-jab-3312-c22867e75e | Not recorded | Not recorded | other-or-unclear | COMPLETED |
JNJ-78306358Source studies (1)Record ID: I-CTG-jnj-78306358-208bd1f312 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
KL-140Source studies (1)Record ID: I-CTG-kl-140-f567d37d02 | Not recorded | Not recorded | conventional-cytotoxic-regimen | TERMINATED |
KRAS BRAF mutant Sintilimab + regafinilSource studies (1)Record ID: I-CTG-kras-braf-mutant-sintilimab-regafinil-1470da0aa8 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
l-LVSource studies (1)Record ID: I-CTG-l-lv-732e59f83b | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
L-OHP (130mg/m2)Source studies (1)Record ID: I-CTG-l-ohp-130mg-m2-eefa83ccf2 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
L-OHP (85 mg/m2)Source studies (1)Record ID: I-CTG-l-ohp-85-mg-m2-4da8ea34dd | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
Labetuzumab Govitecan (LG)Source studies (1)Record ID: I-CTG-labetuzumab-govitecan-lg-76b9d44000 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Laboratory Biomarker AnalysisSource studies (13)Record ID: I-CTG-laboratory-biomarker-analysis-5dff388dd6 | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING / COMPLETED / TERMINATED |
Laboratory testSource studies (1)Record ID: I-CTG-laboratory-test-905b6fc4d1 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
LB-100Source studies (1)Record ID: I-CTG-lb-100-99b29ca4a0 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
LC Bead M1Source studies (1)Record ID: I-CTG-lc-bead-m1-cae64da0e3 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
LenalidomideSource studies (1)Record ID: I-CTG-lenalidomide-5f0194b3aa | Not recorded | Not recorded | other-or-unclear | COMPLETED |
LenvatinibSource studies (1)Record ID: I-CTG-lenvatinib-949cb28155 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
leucovorinSource studies (11)Record ID: I-CTG-leucovorin-477cf9e8e1 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED / RECRUITING / TERMINATED / UNKNOWN / WITHDRAWN |
Leucovorin CalciumSource studies (6)Record ID: I-CTG-leucovorin-calcium-12cd7dfb0d | Not recorded | Not recorded | other-or-unclear | COMPLETED / RECRUITING / TERMINATED |
LGX818Source studies (1)Record ID: I-CTG-lgx818-7201f7370f | Not recorded | Not recorded | other-or-unclear | COMPLETED |
LomotilSource studies (1)Record ID: I-CTG-lomotil-2f49e64322 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Long Course Chemoradiotherapy (LCRT)Source studies (1)Record ID: I-CTG-long-course-chemoradiotherapy-lcrt-8ef4c30b58 | Not recorded | Not recorded | radiation | COMPLETED |
Long Range NGS HLA typingSource studies (1)Record ID: I-CTG-long-range-ngs-hla-typing-81c163d1b8 | Not recorded | Not recorded | diagnostic-test | RECRUITING |
LorigerlimabSource studies (1)Record ID: I-CTG-lorigerlimab-bce46b3b96 | Not recorded | Not recorded | bispecific-antibody | COMPLETED |
lorlatinibSource studies (1)Record ID: I-CTG-lorlatinib-dd395f4ea5 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
LovazaSource studies (1)Record ID: I-CTG-lovaza-27b865bab7 | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
Low dose [177Lu]Lu-A9-0631Source studies (1)Record ID: I-CTG-low-dose-177lu-lu-a9-0631-59fb059ef2 | Not recorded | Not recorded | radioligand-therapy | RECRUITING |
LY2157299Source studies (1)Record ID: I-CTG-ly2157299-6d0eb5d7f4 | Not recorded | Not recorded | small-molecule | ACTIVE_NOT_RECRUITING |
LY4257496Source studies (1)Record ID: I-CTG-ly4257496-f47e0b6be4 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
LY4257529Source studies (1)Record ID: I-CTG-ly4257529-a6560d255b | Not recorded | Not recorded | diagnostic-test | RECRUITING |
LycopeneSource studies (1)Record ID: I-CTG-lycopene-8fe10f92e2 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
LYL273Source studies (1)Record ID: I-CTG-lyl273-4b65a0f719 | Not recorded | Not recorded | car-t-cell-therapy | RECRUITING |
LymphodepletionSource studies (1)Record ID: I-CTG-lymphodepletion-d9aa4bb4f0 | Not recorded | Not recorded | car-nk-cell-therapy | RECRUITING |
m-FOLFOX-6 regimenSource studies (1)Record ID: I-CTG-m-folfox-6-regimen-e461ed5c58 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Magnesium glycinateSource studies (1)Record ID: I-CTG-magnesium-glycinate-357334ce51 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Magnesium-rich mineral water (Rozana)Source studies (1)Record ID: I-CTG-magnesium-rich-mineral-water-rozana-b593c89603 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
Magnetic Resonance ElastographySource studies (1)Record ID: I-CTG-magnetic-resonance-elastography-c2f988514f | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
Magnetic Resonance ImagingSource studies (11)Record ID: I-CTG-magnetic-resonance-imaging-8db75186a3 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING / ENROLLING_BY_INVITATION / RECRUITING |
magnetic resonance imaging with positron emission tomography scanningSource studies (1)Record ID: I-CTG-magnetic-resonance-imaging-with-positron-e-a3601d6508 | Not recorded | Not recorded | procedure-or-device | TERMINATED |
MammogramSource studies (1)Record ID: I-CTG-mammogram-670591afa3 | Not recorded | Not recorded | diagnostic-test | UNKNOWN |
MCLA-129Source studies (1)Record ID: I-CTG-mcla-129-5e5c8330bb | Not recorded | Not recorded | bispecific-antibody | ACTIVE_NOT_RECRUITING |
MDX-1106Source studies (1)Record ID: I-CTG-mdx-1106-4f4f9f6015 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
MDX2001Source studies (1)Record ID: I-CTG-mdx2001-28c05f2fd6 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Medical Chart ReviewSource studies (1)Record ID: I-CTG-medical-chart-review-5ba239bed0 | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
Medical history and physical examinationSource studies (1)Record ID: I-CTG-medical-history-and-physical-examination-a10d3d3eb0 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
MelCancerVacSource studies (1)Record ID: I-CTG-melcancervac-62927713d3 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
MetforminSource studies (1)Record ID: I-CTG-metformin-c18f8cceb7 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
MetoclopramideSource studies (1)Record ID: I-CTG-metoclopramide-8ddbc3c706 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
MetronidazoleSource studies (2)Record ID: I-CTG-metronidazole-524a0b3040 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
mFOLFOX6Source studies (5)Record ID: I-CTG-mfolfox6-4bcab81a9c | Not recorded | Not recorded | conventional-cytotoxic-regimen | ACTIVE_NOT_RECRUITING / COMPLETED / NOT_YET_RECRUITING |
mitomycin CSource studies (1)Record ID: I-CTG-mitomycin-c-1fbfe1c12b | Not recorded | Not recorded | other-or-unclear | TERMINATED |
MK-0646Source studies (1)Record ID: I-CTG-mk-0646-4fd2f3ddeb | Not recorded | Not recorded | conventional-cytotoxic-regimen | WITHDRAWN |
MK-1697Source studies (1)Record ID: I-CTG-mk-1697-c2f0cfd65b | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Modified FOLFOXSource studies (1)Record ID: I-CTG-modified-folfox-8e88d4b748 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Modified FOLFOX6Source studies (1)Record ID: I-CTG-modified-folfox6-c371e07b89 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Modified Vaccinia Virus Ankara Vaccine Expressing p53Source studies (1)Record ID: I-CTG-modified-vaccinia-virus-ankara-vaccine-exp-01c7ba8124 | Not recorded | Not recorded | vaccine | ACTIVE_NOT_RECRUITING |
ModotuximabSource studies (1)Record ID: I-CTG-modotuximab-e59aed6c41 | Not recorded | Not recorded | antibody | TERMINATED |
MonalizumabSource studies (1)Record ID: I-CTG-monalizumab-b20b5f3a0f | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
Monalizumab/MEDI5257Source studies (1)Record ID: I-CTG-monalizumab-medi5257-aa7dcbff79 | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
MRISource studies (1)Record ID: I-CTG-mri-86b3733153 | Not recorded | Not recorded | diagnostic-test | TERMINATED |
MRI scanSource studies (1)Record ID: I-CTG-mri-scan-8b04e2b9bb | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
MSB0011359CSource studies (1)Record ID: I-CTG-msb0011359c-a7e415b949 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
MT-304Source studies (1)Record ID: I-CTG-mt-304-191b938129 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
MT-304 + NivolumabSource studies (1)Record ID: I-CTG-mt-304-nivolumab-6d974fa050 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Multi-mode tumor treatment systemSource studies (2)Record ID: I-CTG-multi-mode-tumor-treatment-system-db11679dc4 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING / RECRUITING |
Multigated Acquisition ScanSource studies (1)Record ID: I-CTG-multigated-acquisition-scan-9e1daf79ee | Not recorded | Not recorded | procedure-or-device | RECRUITING |
Multimodal Deep Learning Model AnalysisSource studies (1)Record ID: I-CTG-multimodal-deep-learning-model-analysis-86746ee930 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
MVT-5873Source studies (1)Record ID: I-CTG-mvt-5873-fbf4e8bac1 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
N-803Source studies (1)Record ID: I-CTG-n-803-891d9321ab | Not recorded | Not recorded | other-or-unclear | COMPLETED |
nab paclitaxelSource studies (1)Record ID: I-CTG-nab-paclitaxel-78f836ff99 | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
nab-PaclitaxelSource studies (1)Record ID: I-CTG-nab-paclitaxel-876379c6c9 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Nanrilkefusp alfaSource studies (2)Record ID: I-CTG-nanrilkefusp-alfa-b7922c4227 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Narrow band imagingSource studies (1)Record ID: I-CTG-narrow-band-imaging-5c2930fe9c | Not recorded | Not recorded | procedure-or-device | WITHDRAWN |
Natural Killer (NK) CellsSource studies (1)Record ID: I-CTG-natural-killer-nk-cells-025ec9bc0f | Not recorded | Not recorded | other-or-unclear | COMPLETED |
NBI FunctionSource studies (2)Record ID: I-CTG-nbi-function-4db99cb116 | Not recorded | Not recorded | procedure-or-device | COMPLETED / UNKNOWN |
NEO212 Oral CapsuleSource studies (1)Record ID: I-CTG-neo212-oral-capsule-cedf19c5ce | Not recorded | Not recorded | other-or-unclear | RECRUITING |
neoadjuvant therapySource studies (1)Record ID: I-CTG-neoadjuvant-therapy-49585eb21a | Not recorded | Not recorded | procedure-or-device | COMPLETED |
NeoTCR-P1 adoptive cell therapySource studies (1)Record ID: I-CTG-neotcr-p1-adoptive-cell-therapy-7c65a49604 | Not recorded | Not recorded | cellular-therapy | SUSPENDED |
NexavarSource studies (1)Record ID: I-CTG-nexavar-22e25f1d4c | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Next Generation Sequencing (NGS)Source studies (1)Record ID: I-CTG-next-generation-sequencing-ngs-fe6f9c3d40 | Not recorded | Not recorded | diagnostic-test | RECRUITING |
NHS-IL12Source studies (1)Record ID: I-CTG-nhs-il12-c6e5b8268b | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Nimotuzumab and chemotherapySource studies (1)Record ID: I-CTG-nimotuzumab-and-chemotherapy-70271ffbe9 | Not recorded | Not recorded | conventional-cytotoxic-regimen | UNKNOWN |
NintedanibSource studies (1)Record ID: I-CTG-nintedanib-45ffbcd092 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Nivolumab + RelatlimabSource studies (1)Record ID: I-CTG-nivolumab-relatlimab-c697e48401 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
NK CellsSource studies (1)Record ID: I-CTG-nk-cells-0545a45d30 | Not recorded | Not recorded | cellular-therapy | RECRUITING |
Nogapendekin AlfaSource studies (1)Record ID: I-CTG-nogapendekin-alfa-ebbb83472c | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
Non interventional studySource studies (1)Record ID: I-CTG-non-interventional-study-32c67f44dd | Not recorded | Not recorded | other-or-unclear | COMPLETED |
non-ICGSource studies (1)Record ID: I-CTG-non-icg-1c4db64104 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
NPC-1C/NEO-102Source studies (1)Record ID: I-CTG-npc-1c-neo-102-6e847a3366 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
NPX267Source studies (1)Record ID: I-CTG-npx267-9503d7abf9 | Not recorded | Not recorded | other-or-unclear | SUSPENDED |
NV1020Source studies (1)Record ID: I-CTG-nv1020-10d6ab1e16 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
OB-002Source studies (1)Record ID: I-CTG-ob-002-f64eed50f8 | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
ObinutuzumabSource studies (1)Record ID: I-CTG-obinutuzumab-27a705e961 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
OlaparibSource studies (1)Record ID: I-CTG-olaparib-a02f1e209b | Not recorded | binder; inhibitor | conventional-cytotoxic-regimen | ACTIVE_NOT_RECRUITING |
On-Treatment BiopsySource studies (1)Record ID: I-CTG-on-treatment-biopsy-2778688f6b | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
ONCR-177Source studies (1)Record ID: I-CTG-oncr-177-b2c5097c90 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Optical coherence tomography probeSource studies (1)Record ID: I-CTG-optical-coherence-tomography-probe-bcc09f15e0 | Not recorded | Not recorded | procedure-or-device | TERMINATED |
Optical spectral reflectance and autofluorescence imagingSource studies (1)Record ID: I-CTG-optical-spectral-reflectance-and-autofluor-d48d84bdf6 | Not recorded | molecular-imaging | molecular-imaging-agent | COMPLETED |
OsimertinibSource studies (1)Record ID: I-CTG-osimertinib-83b1b6c8b8 | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
oxaliplatinSource studies (26)NCT00061815 NCT00125034 NCT00199797 NCT00226941 NCT00444678 NCT00647530 NCT00803647 NCT01167725 NCT01225744 NCT01442935 NCT01588990 NCT01955629 NCT02848443 NCT03169777 NCT03607643 NCT04262687 NCT05307198 NCT05719558 NCT05720559 NCT05774964 NCT05794750 NCT05914389 NCT06490536 NCT06696768 NCT07318805 NCT07503756 Record ID: I-CTG-oxaliplatin-217ec63088 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED / NOT_YET_RECRUITING / RECRUITING / TERMINATED / UNKNOWN / WITHDRAWN |
Oxaliplatin (Eloxatin) + Fluorouracil + folinic acidSource studies (1)Record ID: I-CTG-oxaliplatin-eloxatin-fluorouracil-folinic--25baf1aa13 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Oxaliplatin, CapecitabineSource studies (1)Record ID: I-CTG-oxaliplatin-capecitabine-ff0e23ed84 | Not recorded | Not recorded | conventional-cytotoxic-regimen | TERMINATED |
Oxaliplatin, Capecitabine, PanitumumabSource studies (1)Record ID: I-CTG-oxaliplatin-capecitabine-panitumumab-7f1f26bbad | Not recorded | Not recorded | conventional-cytotoxic-regimen | TERMINATED |
Pabolizumab+ bevacizumab and CapeOX (bevacizumab + oxaliplatin + capecitabine)Source studies (1)Record ID: I-CTG-pabolizumab-bevacizumab-and-capeox-bevaciz-9c1b6a42fb | Not recorded | Not recorded | antibody | UNKNOWN |
PaclitaxelSource studies (2)Record ID: I-CTG-paclitaxel-2662a98344 | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING / TERMINATED |
PalbociclibSource studies (1)Record ID: I-CTG-palbociclib-f8ab549720 | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
pancreatectomy or hepatectomySource studies (1)Record ID: I-CTG-pancreatectomy-or-hepatectomy-c32742d453 | Not recorded | Not recorded | procedure-or-device | COMPLETED |
Panitumumab (Part 1a only)Source studies (1)Record ID: I-CTG-panitumumab-part-1a-only-fa5aed2249 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Panitumumab + FOLFOX (DP)Source studies (1)Record ID: I-CTG-panitumumab-folfox-dp-a74d96e257 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Panitumumab + FOLFOX (no-DP)Source studies (1)Record ID: I-CTG-panitumumab-folfox-no-dp-c31419ac32 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Panitumumab 20 milligram/MLSource studies (1)Record ID: I-CTG-panitumumab-20-milligram-ml-b5aa88c37a | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Panitumumab with capecitabine and oxaliplatin (CAPOX) followed bySource studies (1)Record ID: I-CTG-panitumumab-with-capecitabine-and-oxalipla-75b2d60e4a | Not recorded | Not recorded | conventional-cytotoxic-regimen | WITHDRAWN |
Panitumumab with capecitabine and radiationSource studies (1)Record ID: I-CTG-panitumumab-with-capecitabine-and-radiatio-3c589bacfc | Not recorded | Not recorded | conventional-cytotoxic-regimen | WITHDRAWN |
PANVAC-FSource studies (1)Record ID: I-CTG-panvac-f-cda251040f | Not recorded | Not recorded | other-or-unclear | COMPLETED |
PANVAC-VSource studies (1)Record ID: I-CTG-panvac-v-abadae5abc | Not recorded | Not recorded | other-or-unclear | COMPLETED |
ParacentesisSource studies (1)Record ID: I-CTG-paracentesis-716ce570e3 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
Part 1 TPST-1120Source studies (1)Record ID: I-CTG-part-1-tpst-1120-6adb3ad37b | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Part 2 TPST-1120 + nivolumabSource studies (1)Record ID: I-CTG-part-2-tpst-1120-nivolumab-eed7a87307 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Part 3 TPST-1120Source studies (1)Record ID: I-CTG-part-3-tpst-1120-12beb5165a | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Part 4 TPST-1120 + nivolumabSource studies (1)Record ID: I-CTG-part-4-tpst-1120-nivolumab-b109e23900 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Patient Control Analgesia (PCA) MorphineSource studies (1)Record ID: I-CTG-patient-control-analgesia-pca-morphine-86f8799359 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Patient NavigationSource studies (1)Record ID: I-CTG-patient-navigation-a0550250d8 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Patient ObservationSource studies (1)Record ID: I-CTG-patient-observation-007d5aee2e | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Patritumab DeruxtecanSource studies (1)Record ID: I-CTG-patritumab-deruxtecan-266372e24a | Not recorded | Not recorded | other-or-unclear | TERMINATED |
PazopanibSource studies (1)Record ID: I-CTG-pazopanib-fc47d3a172 | Not recorded | inhibitor | other-or-unclear | COMPLETED |
PB101Source studies (1)Record ID: I-CTG-pb101-433455a932 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
PCASource studies (1)Record ID: I-CTG-pca-4dda90e8db | Not recorded | Not recorded | procedure-or-device | UNKNOWN |
PDR001Source studies (1)Record ID: I-CTG-pdr001-ece896f523 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
PegfilgrastimSource studies (1)Record ID: I-CTG-pegfilgrastim-f08268964f | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Pegylated liposomal doxorubicin (PLD)Source studies (1)Record ID: I-CTG-pegylated-liposomal-doxorubicin-pld-be373b3834 | Not recorded | binder; inhibitor | other-or-unclear | TERMINATED |
Pembrolizumab (MK-3475)Source studies (1)Record ID: I-CTG-pembrolizumab-mk-3475-ef646ad129 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
PemetrexedSource studies (2)Record ID: I-CTG-pemetrexed-e1d4553852 | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING |
Penpulimab injectionSource studies (1)Record ID: I-CTG-penpulimab-injection-7da2c3d9ca | Not recorded | Not recorded | antibody | UNKNOWN |
PeptiCRAd-1Source studies (1)Record ID: I-CTG-pepticrad-1-a6c55038c8 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Performance statusSource studies (1)Record ID: I-CTG-performance-status-d6ee286977 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
PETSource studies (1)Record ID: I-CTG-pet-bbba57318f | Not recorded | Not recorded | diagnostic-test | TERMINATED |
Pexa-VecSource studies (1)Record ID: I-CTG-pexa-vec-4e9eb29c59 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
PF-05212384Source studies (1)Record ID: I-CTG-pf-05212384-24958d3455 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
PF-07284892Source studies (1)Record ID: I-CTG-pf-07284892-c7dd60dbfd | Not recorded | Not recorded | other-or-unclear | TERMINATED |
PF-07329640Source studies (1)Record ID: I-CTG-pf-07329640-371a79391a | Not recorded | Not recorded | other-or-unclear | TERMINATED |
PF-07826390Source studies (1)Record ID: I-CTG-pf-07826390-8e559facb7 | Not recorded | Not recorded | bispecific-antibody | TERMINATED |
PF-08032562Source studies (1)Record ID: I-CTG-pf-08032562-669c79729c | Not recorded | Not recorded | other-or-unclear | RECRUITING |
pharmacological studySource studies (4)Record ID: I-CTG-pharmacological-study-61a08d0ad1 | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING / COMPLETED / TERMINATED |
PHN-010Source studies (1)Record ID: I-CTG-phn-010-a2f9d1e170 | Not recorded | cytotoxic-payload-delivery | antibody-drug-conjugate | TERMINATED |
Photodynamic TherapySource studies (1)Record ID: I-CTG-photodynamic-therapy-c27ebbabef | Not recorded | Not recorded | other-or-unclear | RECRUITING |
PhotographySource studies (1)Record ID: I-CTG-photography-25f3aeb51f | Not recorded | Not recorded | other-or-unclear | TERMINATED |
PlaceboSource studies (7)Record ID: I-CTG-placebo-9c3b89ebaf | Not recorded | Not recorded | conventional-cytotoxic-regimen | ACTIVE_NOT_RECRUITING / COMPLETED / TERMINATED / UNKNOWN / WITHDRAWN |
Placebo AdministrationSource studies (1)Record ID: I-CTG-placebo-administration-51232b6d97 | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
Placebo to vismodegibSource studies (1)Record ID: I-CTG-placebo-to-vismodegib-54ef69d1df | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Plasma circulating DNA analysisSource studies (1)Record ID: I-CTG-plasma-circulating-dna-analysis-6a080be6a4 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
PlerixaforSource studies (1)Record ID: I-CTG-plerixafor-0e8302753d | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Pneumococcal VaccineSource studies (1)Record ID: I-CTG-pneumococcal-vaccine-3a286e3cff | Not recorded | Not recorded | vaccine | TERMINATED |
Polio VaccineSource studies (1)Record ID: I-CTG-polio-vaccine-8bd23171cc | Not recorded | Not recorded | vaccine | TERMINATED |
PolyPEPI1018Source studies (1)Record ID: I-CTG-polypepi1018-d64b014978 | Not recorded | Not recorded | vaccine | COMPLETED |
Positron Emission MammographySource studies (1)Record ID: I-CTG-positron-emission-mammography-0118d1dc52 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
Positron Emission TomographySource studies (10)Record ID: I-CTG-positron-emission-tomography-ffd4d5b3e4 | Not recorded | Not recorded | molecular-imaging-agent | ACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED |
Postoperative dwell with paclitaxel and 5-FUSource studies (1)Record ID: I-CTG-postoperative-dwell-with-paclitaxel-and-5--cbaf1635c9 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Pre-Treatment BiopsySource studies (1)Record ID: I-CTG-pre-treatment-biopsy-a90e655b1d | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
PrednisoneSource studies (1)Record ID: I-CTG-prednisone-4995a7ba74 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Prednisone/ prednisoloneSource studies (1)Record ID: I-CTG-prednisone-prednisolone-ab44bed919 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
ProchlorperazineSource studies (1)Record ID: I-CTG-prochlorperazine-c8ee5fcc08 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Prostate-Specific Antigen TestSource studies (1)Record ID: I-CTG-prostate-specific-antigen-test-69e1daab23 | Not recorded | Not recorded | diagnostic-test | UNKNOWN |
Proton-decoupled 31P MRS at 1.5TSource studies (1)Record ID: I-CTG-proton-decoupled-31p-mrs-at-1-5t-d78a91489f | Not recorded | Not recorded | antibody | COMPLETED |
PY314Source studies (1)Record ID: I-CTG-py314-c569282056 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
QL1706 Drug: mFOLFOX6 Radiation: Short-Course Radiotherapy (SCRT)Source studies (1)Record ID: I-CTG-ql1706-drug-mfolfox6-radiation-short-cours-52e0d55470 | Not recorded | Not recorded | bispecific-antibody | NOT_YET_RECRUITING |
quality-of-life assessmentSource studies (1)Record ID: I-CTG-quality-of-life-assessment-28a9608bcf | Not recorded | Not recorded | procedure-or-device | COMPLETED |
QuestionnaireSource studies (1)Record ID: I-CTG-questionnaire-ba8850dcf4 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Questionnaire AdministrationSource studies (1)Record ID: I-CTG-questionnaire-administration-f956df30f2 | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
Radiation TherapySource studies (3)Record ID: I-CTG-radiation-therapy-0a178cc5e4 | Not recorded | Not recorded | radiation | ACTIVE_NOT_RECRUITING / COMPLETED / TERMINATED |
Radiofrequency ablation therapeutic apparatusSource studies (1)Record ID: I-CTG-radiofrequency-ablation-therapeutic-appara-a642dca4d5 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
Radiologic ExaminationSource studies (1)Record ID: I-CTG-radiologic-examination-9a6ce96111 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
Radiologic Imaging ProcedureSource studies (1)Record ID: I-CTG-radiologic-imaging-procedure-34b1192459 | Not recorded | Not recorded | procedure-or-device | RECRUITING |
RadiotherapySource studies (2)Record ID: I-CTG-radiotherapy-7f9e778d18 | Not recorded | Not recorded | radiation | RECRUITING / TERMINATED |
Raman spectroscopy (SPECTRA IMDx)Source studies (1)Record ID: I-CTG-raman-spectroscopy-spectra-imdx-952b1686c5 | Not recorded | Not recorded | procedure-or-device | UNKNOWN |
Ramucirumab InjectionSource studies (1)Record ID: I-CTG-ramucirumab-injection-5636405d75 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
recombinant fowlpox-CEA(6D)/TRICOM vaccineSource studies (1)Record ID: I-CTG-recombinant-fowlpox-cea-6d-tricom-vaccine-65049cf12c | Not recorded | Not recorded | vaccine | COMPLETED |
Recombinant Fowlpox-GM-CSFSource studies (1)Record ID: I-CTG-recombinant-fowlpox-gm-csf-b0118f1760 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)Source studies (2)Record ID: I-CTG-recombinant-nonavalent-types-6-11-16-18-31-5a6e71a614 | Not recorded | Not recorded | vaccine | COMPLETED |
Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) VaccineSource studies (1)Record ID: I-CTG-recombinant-nonavalent-human-papillomaviru-da7b49af2c | Not recorded | Not recorded | vaccine | COMPLETED |
Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)Source studies (1)Record ID: I-CTG-recombinant-quadrivalent-human-papillomavi-36bae07401 | Not recorded | Not recorded | vaccine | COMPLETED |
RectectomySource studies (1)Record ID: I-CTG-rectectomy-87902c3df2 | Not recorded | Not recorded | procedure-or-device | UNKNOWN |
Regorafenib (BAY 73-4506)Source studies (1)Record ID: I-CTG-regorafenib-bay-73-4506-e8f7d047b9 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
ResectionSource studies (1)Record ID: I-CTG-resection-704a490aaa | Not recorded | Not recorded | procedure-or-device | RECRUITING |
Resection surgerySource studies (1)Record ID: I-CTG-resection-surgery-b8514ede44 | Not recorded | Not recorded | procedure-or-device | UNKNOWN |
RetroviewTM colonoscopeSource studies (1)Record ID: I-CTG-retroviewtm-colonoscope-d6b6d7ed2c | Not recorded | Not recorded | procedure-or-device | COMPLETED |
rF-CEA(6D)/TRICOMSource studies (1)Record ID: I-CTG-rf-cea-6d-tricom-d76022ee81 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
RilvegostomigSource studies (1)Record ID: I-CTG-rilvegostomig-51ddc4cd03 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
RituximabSource studies (1)Record ID: I-CTG-rituximab-2e49eb3c34 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
RO7515629Source studies (1)Record ID: I-CTG-ro7515629-a1f49e9aff | Not recorded | Not recorded | other-or-unclear | TERMINATED |
RogaratinibSource studies (1)Record ID: I-CTG-rogaratinib-f1e5447552 | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
rV-CEA(6D)/TRICOM-rF-CEA(6D)/TRICOMSource studies (1)Record ID: I-CTG-rv-cea-6d-tricom-rf-cea-6d-tricom-6ecc12eb4e | Not recorded | Not recorded | other-or-unclear | COMPLETED |
S-1Source studies (2)Record ID: I-CTG-s-1-6a840baf5d | Not recorded | Not recorded | other-or-unclear | UNKNOWN / WITHDRAWN |
S-1, BevacizumabSource studies (1)Record ID: I-CTG-s-1-bevacizumab-b11d2b44f6 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
S-1, Irinotecan, BevacizumabSource studies (2)Record ID: I-CTG-s-1-irinotecan-bevacizumab-ed76068ac9 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
S-531011Source studies (1)Record ID: I-CTG-s-531011-71168055f0 | Not recorded | Not recorded | other-or-unclear | NOT_YET_RECRUITING |
S1Source studies (2)Record ID: I-CTG-s1-e8bc163c82 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
SamplingSource studies (1)Record ID: I-CTG-sampling-52630e4131 | Not recorded | Not recorded | other-or-unclear | NOT_YET_RECRUITING |
Sargramostim (GM-CSF, Leukine)Source studies (1)Record ID: I-CTG-sargramostim-gm-csf-leukine-d29647800f | Not recorded | Not recorded | vaccine | COMPLETED |
Screening Questionnaire AdministrationSource studies (1)Record ID: I-CTG-screening-questionnaire-administration-0a65b6feb4 | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
Serum metabolomic analysis or ELISASource studies (1)Record ID: I-CTG-serum-metabolomic-analysis-or-elisa-71fe764949 | Not recorded | Not recorded | other-or-unclear | NOT_YET_RECRUITING |
Short Course Radiotherapy (SCRT)Source studies (1)Record ID: I-CTG-short-course-radiotherapy-scrt-0d75e0f8f8 | Not recorded | Not recorded | radiation | COMPLETED |
SigmoidoscopySource studies (1)Record ID: I-CTG-sigmoidoscopy-4dbc0d4ee1 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
single photon emission computed tomographySource studies (1)Record ID: I-CTG-single-photon-emission-computed-tomography-fa3b449559 | Not recorded | Not recorded | procedure-or-device | COMPLETED |
Sintilimab+Cetuximab+Chemotherapy (mFOLFOX6/FOLFIRI/CAPEOX/CAPIRI)Source studies (1)Record ID: I-CTG-sintilimab-cetuximab-chemotherapy-mfolfox6-6f8c632ed7 | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING |
Sintilimab,regofinib,cetuximabSource studies (1)Record ID: I-CTG-sintilimab-regofinib-cetuximab-4ca21f4c71 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
SIR-SphereSource studies (1)Record ID: I-CTG-sir-sphere-80cf50063d | Not recorded | Not recorded | radioligand-therapy | COMPLETED |
Sir-SpheresSource studies (1)Record ID: I-CTG-sir-spheres-bd0d6f6e70 | Not recorded | Not recorded | radioligand-therapy | COMPLETED |
SNB-101Source studies (1)Record ID: I-CTG-snb-101-9f3414b5ea | Not recorded | Not recorded | other-or-unclear | COMPLETED |
SNK01Source studies (1)Record ID: I-CTG-snk01-622d96f88e | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
Sodium ValproateSource studies (1)Record ID: I-CTG-sodium-valproate-ad466db77f | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
Sofe-MSource studies (1)Record ID: I-CTG-sofe-m-d6f06a2647 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
SotigalimabSource studies (1)Record ID: I-CTG-sotigalimab-44c2a2ac30 | Not recorded | Not recorded | other-or-unclear | ENROLLING_BY_INVITATION |
SPECT/CT scanSource studies (1)Record ID: I-CTG-spect-ct-scan-f23d165d06 | Not recorded | Not recorded | radiation | UNKNOWN |
SpinalSource studies (1)Record ID: I-CTG-spinal-6676403310 | Not recorded | Not recorded | procedure-or-device | UNKNOWN |
Spinal analgesiaSource studies (1)Record ID: I-CTG-spinal-analgesia-c430588c7a | Not recorded | Not recorded | other-or-unclear | COMPLETED |
SPLIT AbsSource studies (1)Record ID: I-CTG-split-abs-568a6369c5 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Standard of CareSource studies (1)Record ID: I-CTG-standard-of-care-2154d8c49a | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
Standard of Care Anticancer TherapiesSource studies (1)Record ID: I-CTG-standard-of-care-anticancer-therapies-ca35c42b0d | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING |
STAR0602Source studies (1)Record ID: I-CTG-star0602-0e31bea916 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Stereotactic Body Radiation TherapySource studies (2)Record ID: I-CTG-stereotactic-body-radiation-therapy-50b9b943a9 | Not recorded | Not recorded | radiation | RECRUITING / WITHDRAWN |
stereotactic body radiation treatment (SBRT)Source studies (1)Record ID: I-CTG-stereotactic-body-radiation-treatment-sbrt-f2d353b710 | Not recorded | Not recorded | radiation | RECRUITING |
sunitinib added to FOLFIRISource studies (1)Record ID: I-CTG-sunitinib-added-to-folfiri-740e02fad6 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
SuntentSource studies (1)Record ID: I-CTG-suntent-c1d3a1ed5b | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Supportive treatmentSource studies (1)Record ID: I-CTG-supportive-treatment-374c0d91c4 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
SurgerySource studies (2)Record ID: I-CTG-surgery-fc00eb484b | Not recorded | Not recorded | procedure-or-device | COMPLETED |
Surgery and Radiation TherapySource studies (1)Record ID: I-CTG-surgery-and-radiation-therapy-1f3ec33ef0 | Not recorded | Not recorded | procedure-or-device | WITHDRAWN |
Surgical ProcedureSource studies (1)Record ID: I-CTG-surgical-procedure-4c06a922cd | Not recorded | Not recorded | procedure-or-device | RECRUITING |
surveillance program after completion of primary treatmentSource studies (1)Record ID: I-CTG-surveillance-program-after-completion-of-p-5da708d826 | Not recorded | Not recorded | conventional-cytotoxic-regimen | COMPLETED |
Survey AdministrationSource studies (1)Record ID: I-CTG-survey-administration-bb8be55b97 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
SY-5609Source studies (1)Record ID: I-CTG-sy-5609-026f831140 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Sym004Source studies (3)Record ID: I-CTG-sym004-e0e4b03009 | Not recorded | binder | antibody | TERMINATED / WITHDRAWN |
Sym004 (12 mg/kg)Source studies (1)Record ID: I-CTG-sym004-12-mg-kg-421e2d5840 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Sym004 (9/6 mg/kg)Source studies (1)Record ID: I-CTG-sym004-9-6-mg-kg-06c895353e | Not recorded | Not recorded | other-or-unclear | COMPLETED |
SYN004Source studies (1)Record ID: I-CTG-syn004-98f543afc6 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Synthetic Tumor-Associated Peptide Vaccine TherapySource studies (1)Record ID: I-CTG-synthetic-tumor-associated-peptide-vaccine-c83b521589 | Not recorded | Not recorded | vaccine | ENROLLING_BY_INVITATION |
TAA06 injectionSource studies (1)Record ID: I-CTG-taa06-injection-bab9f355e9 | Not recorded | Not recorded | car-t-cell-therapy | UNKNOWN |
TACESource studies (1)Record ID: I-CTG-tace-1c10c95381 | Not recorded | Not recorded | procedure-or-device | COMPLETED |
Tailored surgerySource studies (1)Record ID: I-CTG-tailored-surgery-c768a57377 | Not recorded | Not recorded | procedure-or-device | TERMINATED |
Talimogene LaherparepvecSource studies (1)Record ID: I-CTG-talimogene-laherparepvec-7f8686419b | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
TAS-102Source studies (6)Record ID: I-CTG-tas-102-0cc3712f32 | Not recorded | Not recorded | other-or-unclear | COMPLETED / NOT_YET_RECRUITING / RECRUITING |
TAS-115Source studies (1)Record ID: I-CTG-tas-115-4a45b73319 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
TAS-116Source studies (1)Record ID: I-CTG-tas-116-d30001104c | Not recorded | Not recorded | other-or-unclear | RECRUITING |
TAS-120Source studies (1)Record ID: I-CTG-tas-120-05739c5158 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
TB511Source studies (1)Record ID: I-CTG-tb511-1f505b7653 | Not recorded | binder | other-or-unclear | NOT_YET_RECRUITING |
TC-510Source studies (1)Record ID: I-CTG-tc-510-9b1833ab76 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
TemozolomideSource studies (3)Record ID: I-CTG-temozolomide-fb2da10619 | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING / UNKNOWN |
TepotinibSource studies (1)Record ID: I-CTG-tepotinib-3d05149ad4 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
Texture and Color Enhancement Imaging (TXI) and Red Dichromatic Imaging (RDI)Source studies (1)Record ID: I-CTG-texture-and-color-enhancement-imaging-txi--eb14ffad61 | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
TF2/IMP288Source studies (1)Record ID: I-CTG-tf2-imp288-e51344a77e | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
The P1 Check-Cap capsuleSource studies (1)Record ID: I-CTG-the-p1-check-cap-capsule-c18b3f27b1 | Not recorded | Not recorded | procedure-or-device | TERMINATED |
therapeutic autologous dendritic cellsSource studies (1)Record ID: I-CTG-therapeutic-autologous-dendritic-cells-5fb7aea80f | Not recorded | Not recorded | cellular-therapy | COMPLETED |
therapeutic autologous lymphocytesSource studies (1)Record ID: I-CTG-therapeutic-autologous-lymphocytes-df7f58a66d | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Therapeutic Conventional SurgerySource studies (2)Record ID: I-CTG-therapeutic-conventional-surgery-338b35cbac | Not recorded | Not recorded | procedure-or-device | TERMINATED / WITHDRAWN |
tissue biopsySource studies (1)Record ID: I-CTG-tissue-biopsy-4563eb941c | Not recorded | Not recorded | other-or-unclear | RECRUITING |
TLR8 Agonist VTX-2337Source studies (1)Record ID: I-CTG-tlr8-agonist-vtx-2337-94adde9273 | Not recorded | agonist | other-or-unclear | TERMINATED |
TME surgerySource studies (1)Record ID: I-CTG-tme-surgery-574b272c1c | Not recorded | Not recorded | conventional-cytotoxic-regimen | NOT_YET_RECRUITING |
TMT212Source studies (1)Record ID: I-CTG-tmt212-c2703c9f1c | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Total Mesorectal ExcisionSource studies (1)Record ID: I-CTG-total-mesorectal-excision-05ac87e6b3 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
Total mesorectal excision (TME)Source studies (1)Record ID: I-CTG-total-mesorectal-excision-tme-cfef43fa3a | Not recorded | Not recorded | procedure-or-device | TERMINATED |
TQB2101 for injectionSource studies (1)Record ID: I-CTG-tqb2101-for-injection-9460dec982 | Not recorded | cytotoxic-payload-delivery | antibody-drug-conjugate | NOT_YET_RECRUITING |
TrametinibSource studies (1)Record ID: I-CTG-trametinib-fd739ca975 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Trastuzumab-Deruxtecan (T-DXd)Source studies (1)Record ID: I-CTG-trastuzumab-deruxtecan-t-dxd-094319d6cd | Not recorded | Not recorded | other-or-unclear | RECRUITING |
TRC102Source studies (1)Record ID: I-CTG-trc102-33d32944bb | Not recorded | Not recorded | other-or-unclear | COMPLETED |
TremelimumabSource studies (1)Record ID: I-CTG-tremelimumab-b96a065b39 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
TRICOM-CEA(6D)Source studies (1)Record ID: I-CTG-tricom-cea-6d-a240edb949 | Not recorded | Not recorded | cellular-therapy | COMPLETED |
Trifluridine + TipiracilSource studies (1)Record ID: I-CTG-trifluridine-tipiracil-bc0eab59a7 | Not recorded | Not recorded | conventional-cytotoxic-regimen | RECRUITING |
Trifluridine and Tipiracil HydrochlorideSource studies (1)Record ID: I-CTG-trifluridine-and-tipiracil-hydrochloride-54105ecac7 | Not recorded | Not recorded | other-or-unclear | WITHDRAWN |
Trifluridine-TipiracilSource studies (2)Record ID: I-CTG-trifluridine-tipiracil-0ce439aa95 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Trifluridine/TipiracilSource studies (2)Record ID: I-CTG-trifluridine-tipiracil-0032e66d66 | Not recorded | Not recorded | other-or-unclear | COMPLETED / RECRUITING |
Trifluridine/tipiracil (TAS-102) combined with bevacizumab and ptemizumabSource studies (1)Record ID: I-CTG-trifluridine-tipiracil-tas-102-combined-wi-6cfdffa038 | Not recorded | Not recorded | other-or-unclear | NOT_YET_RECRUITING |
Trifluridine/tipiracil + bevacizumabSource studies (1)Record ID: I-CTG-trifluridine-tipiracil-bevacizumab-deb2085f44 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Trifluridine/Tipiracil + RegorafenibSource studies (1)Record ID: I-CTG-trifluridine-tipiracil-regorafenib-1dbf1c0555 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Trifluridine/Tipiracil HydrochlorideSource studies (1)Record ID: I-CTG-trifluridine-tipiracil-hydrochloride-7dd4f1b568 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Trifluridine/tipiracil hydrochloride (S 95005)Source studies (1)Record ID: I-CTG-trifluridine-tipiracil-hydrochloride-s-950-acc4c34069 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
TripleitriumabSource studies (1)Record ID: I-CTG-tripleitriumab-75cead04cb | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
TSR-033Source studies (1)Record ID: I-CTG-tsr-033-9cd9a29917 | Not recorded | Not recorded | antibody | COMPLETED |
TTX-MC138Source studies (1)Record ID: I-CTG-ttx-mc138-2165742de0 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Tumor Infiltrating Lymphocytes (TIL)Source studies (1)Record ID: I-CTG-tumor-infiltrating-lymphocytes-til-8887df852c | Not recorded | Not recorded | other-or-unclear | RECRUITING |
Tumor specific mesorectal excisionSource studies (1)Record ID: I-CTG-tumor-specific-mesorectal-excision-a965cbf0f1 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
Tumor Tissue Collection and NGSSource studies (1)Record ID: I-CTG-tumor-tissue-collection-and-ngs-d22cb69308 | Not recorded | Not recorded | diagnostic-test | RECRUITING |
Tumor tissue sampling for organoid developmentSource studies (1)Record ID: I-CTG-tumor-tissue-sampling-for-organoid-develop-e81a9022da | Not recorded | Not recorded | procedure-or-device | RECRUITING |
UCB4594Source studies (1)Record ID: I-CTG-ucb4594-3b78bd6490 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
UFTSource studies (1)Record ID: I-CTG-uft-94cca6fdcf | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Ultrasound ImagingSource studies (1)Record ID: I-CTG-ultrasound-imaging-8ed1941328 | Not recorded | Not recorded | procedure-or-device | ACTIVE_NOT_RECRUITING |
Vectibix® (panitumumab)Source studies (1)Record ID: I-CTG-vectibix-panitumumab-33e4583e2c | Not recorded | binder | antibody | COMPLETED |
vemurafenibSource studies (2)Record ID: I-CTG-vemurafenib-a383bf2e3e | Not recorded | Not recorded | other-or-unclear | COMPLETED |
VenetoclaxSource studies (1)Record ID: I-CTG-venetoclax-87ebc9d39b | Not recorded | Not recorded | other-or-unclear | COMPLETED |
virtual chromo-endoscopy using FICE Fujifilm TechnologySource studies (1)Record ID: I-CTG-virtual-chromo-endoscopy-using-fice-fujifi-7ac4ba6b09 | Not recorded | Not recorded | procedure-or-device | UNKNOWN |
Virtual ChromoendoscopySource studies (1)Record ID: I-CTG-virtual-chromoendoscopy-5711d066c1 | Not recorded | Not recorded | procedure-or-device | NOT_YET_RECRUITING |
Vismodegib 150 mgSource studies (1)Record ID: I-CTG-vismodegib-150-mg-0d5cf702a9 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Vitamin ASource studies (2)Record ID: I-CTG-vitamin-a-2b6a15c1b9 | Not recorded | Not recorded | other-or-unclear | UNKNOWN |
VolrustomigSource studies (1)Record ID: I-CTG-volrustomig-94a09116dd | Not recorded | Not recorded | other-or-unclear | RECRUITING |
VS-7375Source studies (1)Record ID: I-CTG-vs-7375-6fa272ceb8 | Not recorded | inhibitor | small-molecule | RECRUITING |
XELOX intensive treatment groupSource studies (1)Record ID: I-CTG-xelox-intensive-treatment-group-cee89b6967 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
XmAb®23104Source studies (1)Record ID: I-CTG-xmab23104-e90fd3738f | Not recorded | Not recorded | bispecific-antibody | COMPLETED |
xT-Onco with HLA-LOH AssaySource studies (1)Record ID: I-CTG-xt-onco-with-hla-loh-assay-c4c1cf9999 | Not recorded | Not recorded | diagnostic-test | ACTIVE_NOT_RECRUITING |
Yervoy® (ipilimumab)Source studies (1)Record ID: I-CTG-yervoy-ipilimumab-11ea2964c9 | Not recorded | Not recorded | antibody | COMPLETED |
YMN-A02 1000μgSource studies (1)Record ID: I-CTG-ymn-a02-1000-g-8bb463fc63 | Not recorded | Not recorded | other-or-unclear | NOT_YET_RECRUITING |
YMN-A02 100μgSource studies (1)Record ID: I-CTG-ymn-a02-100-g-c78b72bc51 | Not recorded | Not recorded | other-or-unclear | NOT_YET_RECRUITING |
YMN-A02 250μgSource studies (1)Record ID: I-CTG-ymn-a02-250-g-d0918ed5ef | Not recorded | Not recorded | other-or-unclear | NOT_YET_RECRUITING |
YMN-A02 500μgSource studies (1)Record ID: I-CTG-ymn-a02-500-g-75e7f8f1cb | Not recorded | Not recorded | other-or-unclear | NOT_YET_RECRUITING |
Yttrium-90 Radioembolization with standard systemic therapySource studies (1)Record ID: I-CTG-yttrium-90-radioembolization-with-standard-aaed2e60d5 | Not recorded | Not recorded | radioligand-therapy | NOT_YET_RECRUITING |
ZalutumumabSource studies (1)Record ID: I-CTG-zalutumumab-086552ae75 | Not recorded | Not recorded | other-or-unclear | TERMINATED |
ZanzalintinibSource studies (1)Record ID: I-CTG-zanzalintinib-6d6ea5e2a7 | Not recorded | Not recorded | other-or-unclear | RECRUITING |
ZD6474Source studies (1)Record ID: I-CTG-zd6474-67e2d836a2 | Not recorded | Not recorded | other-or-unclear | COMPLETED |
Ziv-AfliberceptSource studies (1)Record ID: I-CTG-ziv-aflibercept-cb86c45d5b | Not recorded | Not recorded | other-or-unclear | ACTIVE_NOT_RECRUITING |
Treatment data
Directness, disease context, development state, dates, and source references remain in the JSON record.